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Upcoming Events
February 14, Friday
Alumni reception at the meeting of the American Academy
of Orthopaedic Surgeons. San Francisco. CA
Receptions in Califor-nia
Februmy 18 Los Angeles

F('bnlar)' 19 San Diego
February 20 San Francisco
fcbmary 22-28 Continuing Medical Education
Jefferson Ane sthe sia Conference for
Cro ss Count ry and Downhill Skiers
Lone Mountain Ranch. Big Sky. Montana
For information call toll-free 1-888-/EFF-CME
Mal"Ch 1-2 Continuing Medical Education
Imaging of the Shoulder and Elbow with
Emphasis on Medical Clinical Relevance
Jefferson Medical College. Philadelphia
For information call toll -free 1-888 -JEFF-CME

Mm'ch 5-8 Continuing Medical Education
24th Annu al Course in Electrodi agno sis
and Clin ical Neurophy siology
Bluernle Life Sciences Building. Jefferson Medical College
For information call toll -free 1-888 -JEFF-CME

MOl-d. 14, Friday
Parents Day for the Sophomore Clas s and their families

MOl-d. 23 , Sund ay
Alumni reception at the meeting of the American College
of Phy sicians. Philadelphia. PA
Mard. 23 , Sund ay
Alumni reception at the meeting of the American Academy
of D ermatology. San Francisco. CA

Mard. 31-April 4

Continuing Medical Education
Bermuda Shorts for Clinical Anesthesiologists
Sonesta Beach Resort. Bermuda
For information call toll-free 1-888-JEFF-CME

April 4, Frid ay

Continuing Medical Education
De rmatology in General Medicine
jefferson Medical College. Philadelphia . PA
For i nfo rmati on call toll -free 1-888 -)EFF-CME

A,,,il 13-14 Continuing Medical Education
Jefferson Foot and Ankle Advanced Imaging Symposium
Jefferson Medical College. Philadelphia
For information call toll-free 1-888-IEFF-CME

April19-20 Continuing Medical Education
The Fourth Annu al Cardiovascular Radiology Review Weekend
lefferson Medical College. Philadelphia
For information call toll -free 1-888-JEFF -CME

AIJril 24, Thursday
Alumni Annual Business Meeting
Apr-j/ 27 , Sunday
Alumni reception at the meeting of the American College
of Ob stetricians and Gynecologists. Las Vegas. NV

May 9-10 Co nti nui ng Me dica l Education
Jefferson Cytopath ol ogy Review Cou rse
Jefferson Medical College . Philadelphi a
For information call toll -free 1-888 -JEFF-CM E

May 18, Sunday
Alumni reception at the meeting of th e Am erican Psy chiat ric
A ssociation . San Di ego. CA
May 21 , Wednesday
Reception and Dinner . W ilkes-Barr e. PA
May 31 , Saturday Con tinuing M edi cal Education
Cardiology: Balancing the Art and Science
Jefferson Medical College. Philadelphi a
For information call toll -free 1-888 -JEFF-CM E

Reunion Wceltend
june 6 Alumni Banquet
jllnc 7 Clinic Presentations; D ean's Luncheon: Reunion Parties
junc 8 Farewell Brun ch
jllnc 13-21 Continuing Medi cal Education
Barge Trip in Burgundy regi on of France-see page II

[une 22-27 Continuing Me di cal Education
Eastern Shore Medical Symposium . Rehob oth Beach. Delaware
For information call toll -free 1-888-JEFF-CM E
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This issue's cover features computer-ge nerated images of
a potential CD4 -based drug developed at leff (see page 4) .
Rational drug design is pro viding the university wi th fur ther
opportunities in technology transfer (see page 7) and
clinical trials (see page 9).

Ziwei Huang. Ph.D .
directs a team of
scientis ts who use
state-of- the-art
technology to
design new drug s.
like the one
shown on the cover.

Rational Drug Design
Translating Basic Research into New Medicines
n th e front and back covers of thi s issu e, an o rganic
inhibitor (the o range shape) design ed by Dr. Ziwei Huang's
lab or at ory a t Jefferson is shown to bind to a sur face po ck et of
th e C D4 pr ot ein and thus block C D4-me d ia ted T cell responses
inv o lved in tr an splant rejection and a number of autoimmune
di seases . Using a co m pu te r, Dr. Hu an g and his coll eagu es hav e
found thi s o rga nic drug lead which is so suc cess fu lly tailored to
th e nook s and cran nies of th e CD4 protein sur face that it binds
th e CD4 tar get with hi gh affinity and tremendous spec ificity.
Th e discover y of thi s and other potential new drug molecules
using co m pu te r-base d technology is bein g reponed in
th e Proceedings of thc National Acadcmy of Sciences USA
(jan ua ry 7, 199 7 issu e) and is on e of th e lat est examples of
rati onal drug design at Jeff. "This is trul y grou ndb reak ing
wo rk, " says Carlo M. Croce, M.D., Director of Jefferson's
Kimmel Ca nce r Ce nte r and Kimmel Cance r Institute. "Many
o the r protein s di sc over ed her e at th e ce nter can be looked at
in thi s wa y to design new drugs for cance r and othe r human
di seases ."
III /Ilis m1ide, we take CI dose looll CI/ the cur rc ur s rnrus of
j effa soll 's ra/iollal e/nlg e/esigll research , and the [utu re
promise i/ holds [or I-eCl/izillg di e IIl1ivasi/y 's visi oll ill
/rallslatillg basi c sc te nt ijic e/iscovelY ill/o new medi cin es for
die co millg ceun ny,

practi ce of drug di sco ver y. Tradition all y, a typi cal drug
development process takes m or e th an 10 yea rs and cos ts about
$ 100 million . Facin g tod ay's rapid cha nges in th e healt h care
enviro n ment, we can no lon ger afford suc h len gthy and
ex pe ns ive wa ys of finding th erapeuti c age n ts to co mbat human
di seases . Rational drug design solves th ese problem s through
th e use of innovative co m pu te r technol ogy co m bined with
many other di sciplines to spee d th e devel opment process.
It begins with th e id entificati on of a m olecul ar target such as a
protein by geneti c and m olecul ar biol ogical techn iques , and the
structural stu dy of th e tar get by high -resolution crysta llography
and NMR spectrosc opy. Th e struc tural info rm at ion abou t the
target is exploited by th e co m pute r to design pot ential drug
mo lecules that regu lat e th e spec ific fun cti on of th e target.
Th e de signed molecul es ar e th en sy nt hesized and m odified
using peptide and organic che m istry techniques , tested for
biolo gical efficacy in various in vit ro and in vivo assay systems,
and finall y th e mo st promising lead is ge ne ra ted for clinical
trials in humans.

Rati on al drug design (a lso known as struc ture-base d drug
design ) is an eme rging app roac h that is revolutionizing the

"Ratio nal drug de sign has taken roo t at J efferson and received a
tr em endous boost with th e arrival of Dr. Ziwei Huang from the
Universit y of Californ ia, San Fran cisco , in ea rly 1995," says
Rob ert L. Cornis, M.D., Clin ical Direct or of th e Kim mel Cancer
Ce n ter. Th e Rational Dru g Design Progr am was established wit h
th e vision of Dr. Ca rlo Croce and th e stro ng support and
resources provid ed by th e medi cal co llege an d th e university.
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Th e development of th e Medi cal Scie nce
Division at th e Kimmel Ca nce r Ce n te r,
under th e direct ion of Dr. Co m is, ha s
p ro vid ed th e enviro n me nt critical for thi s
typ e of resear ch .
T he pr ojects' recent success is due to many
factors , ex plains Dr. Hu an g. Th e ge neticis ts and mol ecul ar biol ogist s at th e
Kimmel Cancer Institute ha ve di scover ed
man y genes and th eir protein products
implicat ed in va rious patholo gical
co nd itio ns, thus providing a bewildering
array of pot ential tar gets for drug design
J
stud ies. T he es tablis hm ent of th e X-ray
crys tallographic and hi gh -field NM R
After being designed on the computer. molecules are synthes ized and modi fi ed at the
spe ctrosco pic facilities at th e in stitute has
Peptide Synthesi s Facility. located in the Bluernle Life Sciences BUilding and d irected by Dr.
pro vid ed important tool s to obtain
Huang. These potential peptide-based drug s are then put into preclinical studies.
struc tura l information necessary for
initiating th e design o f a drug. Finally, th e com pute r m od eling
cell. C D4 co ntac ts ano the r ant ige n- pres enting protein called
and peptide synt hes is facilities have been esse nt ial.
maj or hist ocompatibility co m plex (MHC) cla ss II duri ng th e
ea rly s tage of th e T ce ll res po nse to an antigen . Because of th is,
Cur rently Dr. Hu an g's lab ha s a network of state -o f-the -art
CD4 pla ys a critica l rol e in regul ating th e immun e syste m
co m pute rs including a four-proc essor mini-supercomput er. Th e
wh ich, if it goes awry , co u ld lead to path ological co nse que nces,
Peptide Synt hesis Facility direct ed by Dr. Huang is eq u ip pe d
suc h as o rga n tran spl ant rejecti on and autoi m m une di seases.
with four full y auto ma ted sy nt hesize rs th at ca n produce hi gh qu alit y, biol ogicall y ac tive peptidcs as pot ential drugs for both
To co ntro l th e undesired immun e res po nse in th ese d iseases ,
sma ll-sca le, in vitro assays and lar ge-scal e, pr eclinical anim al
th er ap eutic stra teg ies suc h as a n anti -CD4 anti bo dy have
stud ies. T hese resear ch in fras truc tu res , together with othe r
been developed . However , th e clini cal value of th ese
ac tivities and progr am s in technology transfer a nd clinical trials
antibod y-based th erapies is limited du e to th eir im m un ogeni cit y
(see th e foll owin g two art icles , pages seve n and nine); ar e
when used in human s . To overco me thi s probl em , Dr. Hu an g's
int egral to Jeffer son 's mission to co m bine stro ng basic research
grou p resort ed to a ra tio na l drug design approach to ge ne ra te
with cli nica l exce llence to devel op a new ge ne ra tio n of human
novel , small m olecul ar CD4 inhibi tors . In co ntra st to an
th er api es .
antibod y, sma ll mole cules (s uc h as peptides o r or ganic
co mpo u nds) are not im m u nogen ic and th erefo re can be used
T he recent devel opm ent of C D4- based drugs by Dr. Hu an g's
for lon g per iod s o f tim e.
team se rves to hi ghlight th e ge ne ral strategy of rational drug
design . CD 4 is a glyco pro te in ex pressed o n th e sur face of a T
Using co m pu te rs , Dr. Hu an g's team looked at th e threedimen sional s hape of th e C D4 prot ein
and design ed s mall pep tid es that co u ld
block C D4- me dia ted im mu ne fun cti on .
Th ese com pu ter design and peptide
synthes is stud ies have led to th e
discover y o f a s mall cyclic hepiapepude
which has been show n by the co llabora ting immun ology lab o rat o ry of Dr.
Rob ert Korngold a t Jefferson to be highl y
effective in anima l mod els for human
multiple sclero sis, or ga n tran splant
rej ecti on , and graft ver sus host di sease
(GVHD) foll owing bon e marro w
tran splantat ion .
The Organ ic Synthesis Facility. recently establi shed within Dr. Huang 's laboratory. provides
an essenti al tool for produ cing a future generation of organic drug s. According to Dr.
Huang, the initial peptide drug s will eventually be replaced by more cost -effective and
orally available orga nic molecul es.
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In ad d ition to th e design of peptide drugs ,
th e co m pute r is also used to selec t
pot ential o rga nic CD4 inh ibitors from
lar ge pools of exis ting co mpo unds. Using

so phisticated mod elin g and graphics so ftwa re, Dr. Huang and
his colleagues have identifi ed promisin g organi c inhibitors of
CD4 function. Co mpared to th e CD4 pept ide drug, th ese
second-genera tion orga nic drugs possess several advantages:
their non-peptidic structures are less susce ptible to enzyma tic
degradation and thus are mor e stable; th ey could be tak en
throu gh the oral route which is most desirabl e in term s of
pati ence co mpliance; and th ey are easily synt hes ized usin g
inexpensive mat erials, which significantly lowers th e cost of the
therapeutic treatm en t.
The compu ter sc reeni ng approach, as dem on strated in th e
discovery of organic CD4 inhibitors , is a pow erful tool in th e
sea rch for perfect drugs. In th e past , man y drugs were found
from a trad ition al process of random sc ree ning of 100,000 to
500,000 compo unds. In con tras t to thi s laborious and expensive
rand om testing, the compu ter-base d strategy as used in th e CD4
study took less than a month to com plete th e scree ning of
approximately 150,000 com pounds , and cos t very littl e since
the testing was do ne on th e co mpute r inst ead of test tub es and
animals. "The orga nic drugs designed by th e com pute r sho uld
be far bett er th an th e ant ibod ies, and th ese studies will ope n
new avenues for th e development of effective medi cin es," says
Hilary Koprowski, M.D., Director ofJ efferson's Center for
euroviro logy.
"Rational d rug desig n is a team effort , and th e CD4 pr oject is a
good example," poin ts out Dr. Huan g. The CD4 peptide and
organic inhibitor stud ies have involved th e computer modelers
and dt ellli sts of Dr. Huan g's lab including Song Li , Taka shi
Sato h, Ji min Gao , Xiaobing Han , Dani el Butch er , Zhaowen Luo ,
Simei Shan, Zhi xian Lu, and Zhe ngdo ng Wu ; th e illllllllllologists
of Dr. Korngo ld's lab in clud ing Th ea M. Friedma n, Andrea E.
Edling, Ute Koch , Swat i Cho ksi, Robert Tow nse nd, J oseph c.
Marini, Ryszard Wia de rkiewicz , and Anna W iad erki ewicz: and
the NMR spect roscop ists of Dr. Markus W . Germann's lab
including J am es M. Aramini. According to Dr. Huang, thi s
multidisciplin ary collaboration and close teamwork have been
essential to the progress mad e in th e CD4 proj ect.

C linical Tr ials Will Begin Soon
Th rough close collabo ration, Dr. Huang, Dr. Korngold , and
clinical colleagues from th e Trans lational Resear ch and Bon e
Marrow Trans plant Program s at th e Kimmel Cance r Center
have progressed to th e point whe re a clinica l trial is imminent.
The remarkable aspec t of th e peptides is that th ere is no toxicity
associa ted with their use in anima ls. Plus there is clear-cut
syne rgy with existing medi cin es used for GVHD in humans
suc h as cyclospo rin . GVHD is th e principa l risk factor affecting
the surv ival of cancer patients undergoin g bone mar row
transpl ant at ion.
Dur ing 1997 the research ers will evalua te both th e side effects
and activity of th e CD4 peptide in pati en ts who are at high risk
for seve re GVHD after bon e marrow tran splantation. Th ese

stu dies will be under the dir ection of Neal Flomenberg '76,
Director of th e Bon e Marrow Tr an spl ant Program . Other clini cal
stu dies of th e peptide will be conduc ted in patients with
multiple sclerosis.
In addi tion to th eir intrins ic impo rta nce, the se initial trials will
lay th e gro undwo rk for employing the new organic mol ecul es
discovered from th e co mpute r scree ning. "We are very excited
abou t th e clinical pot ential of th ese novel CD4 drugs ," says Dr.
Comis. "They will point out th e future direction of our tran slation al resea rch."
Th e CD4-base d drugs, if th ey successfu lly pass human clini cal
trial s and reach th e market , will find many clinical applications
for autoimmune diseases suc h as multiple sclerosis and
rh eumatoid arthritis and bon e mar row and orga n transplantati on . Th eir comme rcial pot enti al will be enormous as there is
an estimated billi on -dollar mark et for suc h drugs.
For thi s reason , J efferson 's drug design programs have attracted
th e atte ntion of a number of pharmaceutical companies an d
investment gro ups which have already expressed stro ng int erest
in working with Jefferson to commercialize th ese d rugs. "The
drug design resear ch carried out at Dr. Huan g's laboratory
represents th e type of broadl y applicable platform technology
th at is parti cul arl y well sui ted for collaboration with indust ry,"
notes jussi j. Saukko ne n , M.D., Dean of the College of Gradu ate
Stud ies and Vice President for Science Policy , Technology
Development, and Int ern ation al Affairs. "The involv em ent of
th e pharmaceutical industry will not only facilitate the
development of comme rcial pr oducts, but also provide
imp ortant finan cial su ppo rt to furt her expa nd the basic research
at J efferson ."
"This is ano the r case substant iating the fact that prog ress in
scie nce is not mad e witho ut risk," observes Joseph S. Gonnella,
M.D., Dean of Jefferson Medi cal College and Senior Vice
Presid ent for Acad emi c Affairs at Th om as J efferson University.
"The univ ersity has mad e a hu ge inves tment in translational
resear ch of wh ich th is effort is a major part. And it is paying off.
Thi s approach will not only save prolon ged trial and error and
bring ben efits to th e pat ient that mu ch sooner, it can also be
expec ted to bring reward s to th e un iversity in increased clini cal
tri als and stro nge r relati on ships with ind us try."
In just two years J efferson's Drug Design Program has gen era ted
a pept ide drug for human clinica l trials and several organi c
molecules in th e pipeline to be deve loped into second
gene ration of cost-effective, ora lly administered drugs.
Most imp ortantly, th e technology develop ed from the se studies
will have gene ral applicati on for developing new medicines for
other human diseases. Rational drug design will playa
prominent role in J efferso n's mission to lin k basic resear ch and
pati ent care. "J efferson is fortu nate to have such a dedicated and
talent ed drug design team ," says Paul C. Brucker , M.D.,
University Presid ent. "I look forwa rd to the futur e development
of th ese tran slati on al research efforts ."

Feature by Malcolm Clendenin
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John j. Gartland 5'44
ince its foun di ng , Jeffe rso n Medical College has earne d a
reputatio n for clinical exce llence and for producin g good
doc tors . Prior to 1980, exce pt for a few bri ght spo ts like th e
Cardeza Founda tion, spo nso red research had not been a
prominent activity at Jefferson . During th e early I980s, th e
Board of Tru st ees of Th oma s Jefferson University
reco mme nde d that th e base for Jefferson 's excellence be
broaden ed by increasing th e research effort. Th e Strategic
Plan adopted by the Board of Tru stees in 1982 recommend ed
a concerted effort be mad e to broad en th e research mission at
Jefferson , and ad di tio nal capital for th e needed faculty and
for th e needed facilities was ap proved. This recommend at ion
and the additional financial sup po rt prese nte d Dean j oseph S.
Gonnella, 1.0 . with a ma nda te to rec rui t mo re resea rchorien ted facu lty while , at the sa me time , to maintain
Jefferson's rep uta tio n for clinica l exce llence. In sho rt order,
Drs. Emanue l Rubin , Darwin Prockop, jouni Uitto, and
Willis Maddrey, amo ng othe rs, jo ined the Jeffe rso n faculty
and formed a research focus whic h , in turn , attracted mor e
research people and more research do llars .

S

There is general agreement amo ng medica l research ins titu tions th at success in an ins titu tio n's research mission is
meas ure d bes t by its share of research dollars obtained
th rou gh compe titive awa rds from th e National Institutes of
Health (N IH). In 1985 Jefferso n obtained five milli on dollars
in NIH fund ing and ranked 78 th in research funding awards
amo ng u.s . medi cal sc hoo ls. By 1995, J efferson had
increased its amo unt of NIH fund ing to 46 milli on dollars
and its research ranking amo ng U.s . medi cal schoo ls had
rise n to the 36th posi tion . The success of Jeffe rso n's research
effort can be understood by considering the rate of increcse of
its share of total fundi ng by the IH. Jeffe rson is seco nd
among all u.s . medical schoo ls in th e rate at which its
portion of total Ll.S, resea rch funding has grown over the
period 1985-95.
The results of good medically orie nted research is scie ntific
achievement which can result in discoveries to im prove
pati ent care , or in tech nologies and produc ts with mar ketable
possibilities. The link between research and pat ient care at
Jefferson is the Office of Clinica l Tria ls (see pages 9-10) . Th e
link be twee n research and indust ry at J efferson is th e Office
of Tec hno logy Tra nsfe r whic h deals with pat ents and licenses
of new d iscove ries or in vention s of faculty or staff. Jefferson 's
link to indu str y bega n to be forged on an ad hoc basis in
1980. The first uni versit y pat ent policy was formulated in
7
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1982, and establis hme nt of th e Office of Technology Tran sfer
followe d in 1984 .
The comme rcial aspec t of a J efferson discovery or inventi on is
handl ed by th e Office of Tec hno logy Tra nsfer. This pro gram
was created at J efferson to capture the oppo rtuni ties in basic
and clini cal research and to develop them int o marke table
products in a tim ely manner. The development of medi cal
technology is a length y process, extendi ng from th e basic
discovery through th e developm en t of products . Thi s is
followe d by labor atory test ing, clinical tria ls, regulatory
approvals, and finally co mmercial introduction. Taking a
technology or product from a basic idea to an actual product
th at can benefit the who le population is a task whi ch may be
accomplis hed bes t by combining th e research and clini cal
capabilities of a un iversity like Jefferson with th e pr odu ct
developm ent , manu factur ing, and marketing capabilities of
indust ry. The technology transfer program at Jefferson see ks
to facilitate th is development by secur ing pat ent pr otect ion to
give indus try the ince ntive to invest significant resources in
developm ent. This is followed by either licensin g th e
tech nology or product to an existi ng company, or to a new
compa ny formed spec ifically to deve lop the new Jefferson
technology or product.
Abram M. Goldfinge r , Director, O ffice of Tech no logy
Tran sfer , has an electrica l engineering degree from M.I.T ., an
M.B.A. degree from th e W ha rto n Schoo l of th e Univer sity of
Pennsylvani a, and an indust ry background in research and
development. He began at J efferson in 198 7 as a bu sin ess
venture analyst in th e Office of Tec hnology Transfer and was
mad e Director in 1991. He likes what he doe s at Jefferson
because it combines science and technology with bu sin ess,
whic h is a goo d fit with his educational background . He says
tha t wor king with Jefferson researchers to see busin esses
crea ted and produc ts developed based on that research is
rewarding. Assistant Director Richard W. Miller has a
bac helor's degree in bio logy and a Master's degree in
ma nage ment and experience in the biotechnology and
phar mace utical ind us try. Administratively, the Office of
Tec hno logy Transfer reports to jussi j. Saukkonen , M.D.
who , in addi tion to being Dean , College of Graduat e Stud ies,
is Vice President for Science Policy , Technol ogy
Development , and Int ern at ion al Affairs. Dr. Saukkon en has
Sign-o ff autho rity on all commercializa tion agre em ent s
negoti ated by th e Office of Tec hno logy Tra nsfer. In add ition ,
Gerald Litwack , Ph.D., Assoc iate Dean for Scientific Affairs,
D e c em b er
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mu st approve agr eem ents inv olvin g resear ch a t Jefferson .
All legal agree me n ts put together by th e Office of Technology
Tra ns fer are reviewed by University Cou nsel before bein g
signed.
In addition , th e techn ology tra nsfer effo rt at Jefferson receives
ove rsigh t both from th e uni versit y and th e Board of Trust ees.
Th e Biotec h no logy Co mm ittee of th e Board of Trust ees was
formed speci fically 10 ove rsee th e Un iversity's effort s and
ac tivities in thi s area. Th is co m rniuec determines how
aggressive a posture J efferson sho uld tak e in th is area, offers
advice and se ts poli cy on suc h acti viti es as th e formati on o f new
co mpa nies and th e taking of equity in new co mpan ies. Th e
Techn ology Transfer Adviso ry Co m mittee, a universit y
mana gem en t co m mittee, is main ly advisory in fu nct ion to
ens ure th at Jefferson's tech nology transfer efforts ar e conducive
to th e gene ral welfare of th e universit y and ar e consisten t wi th
othe r uni versit y objectives.
J efferson 's cur ren t parent poli cy s tipula tes that th e universit y
ow ns th e rights to any inve n tio n mad e or develop ed with
un iversity funds, equ ipme nt, facilities, or personnel. Un iversity
ow ned technology ma y be pat ent ed and licensed eithe r
excl us ively or non -exclusivel y. The in ventor s receiv e a sha re of
th e incom e deriv ed from s uc h licenses, and th e remainder is
applied to resear ch and educational purposes at th e Univ ersit y.
Co pyrigh table works created for university purposes in th e
co u rse of th e creato r's em ploy me n t also ar e owned by th e
uni versit y and licen sed th rough th e Office of Techn ology
Transfer.
The Unive rsi ty Patent Co m mincc plays a ro le in th e
interpretation a nd impl em ent at ion o f th e pat ent poli cy. Cha ired
by Dr. jussi J. Saukko ne n in his capacity as Vice President for
Science Policy and Tec h no logy Development ,
th e Co m mittee membership represent th e faculty and th e
administration and ar e appointed by the Un iversity Presid ent.
Abra m Go ld finge r ex plains how th e technology transfer pro cess
wo rks at J efferson . A Jefferson resear ch er notifi es th e O ffice of
Tec h no logy Tra nsfer of th e devel opment of a new technology or
product which th e resear ch er believes has co mme rcial possibilities. The first step for th e Office of Technology Tr an sfer is to do
a market ana lysis and rev iew th e patentability of th e technology
or product. If th ese reviews are favorabl e, Mr. Goldfinger files
for a pat ent. Whil e it lak es abo u t three yea rs to obtain a patent ,
Go ld finge r points ou t that th e act o f filing for a pa tent
establishes a pr opri etary position for Jefferson whi ch can be
licen sed . Nex t, th e O ffice o f Technol ogy Transfer identifi es
co mpan ies with th e appro priate resources to collaborate with
J efferson in th e development and market ing of th e technology
or pro duc t. Pickin g a co mpa ny as a partner in th e ven ture may
hinge on whe ther th e co mpa ny dem ands an excl us ive co ntrac t
or will acce pt a non -exclusive co ntrac t with J efferson . If an
ex isting co mpany is se lec ted to develop th e technology or
product , Jefferson ge ts licen sin g fees and royalti es and, possibl y,
resear ch funds. Jefferson may decid e that th e best way to

develop th e technology or product is to seek the formation of
a new co mpany . In th at eve nt, th e O ffice of Tec hnology
Transfer develop s an ou tline of a bu sin ess plan and
approach es venture capital firm s or othe r investm en t groups
to form the company. Jefferson gene rally does not invest
funds in th ese ventu res but , once a new co mpany is for med,
Jefferson receives equity in th e co mpa ny and , frequently ,
add itio na l research funding.
Abram Go ld finge r cites two recent exa mples of taking a
J efferson d iscovery to market. A vec tor system for gene
th erapy was develop ed a t J efferson whic h is capable of
co rrec ting erro rs in th e DNA sequence , thu s it may be
broad ly useful for gene th erap y as we ll as in other application s. A pa tent applicati on was gran ted in 1996. License and
research agreeme n ts were signed in 1994 with Kimeragen ,
In c., cwtown, PA, a new co mpa ny form ed to co mmercialize
thi s technology. Th e agreem ent with th e uni versity includes
Jefferson receivin g equ ity in Kimeragen , Inc.
Th e second exa mple invo lves a cancer vacci ne which was
develop ed at Jefferson for trea ting melan om a and oth er forms
of ca ncer. Th e vacc ine uses a pati en t's own tu mor cells which
ar e irr adi ated and mod ified to stimu late an immune response
against othe r tumor cells. Clin ical trials have bee n conducted
in over 200 melanoma pati ent s at Jefferson . After surg ical
removal of the tumor, the vaccin e treatment inc reased the
percent age o f pati ents rem aining di sease-free for four years
from 20 per cent to 60 percent. A pat ent on th e tech nology
was issu ed in 1994 . License and resear ch agreements wer e
signed in 1995 with Avax Tec h no logies , Inc. of Kansa s
City, Missouri , a new co mpa ny forme d to commercialize
th is technology. J efferson rece ives equi ty in th is company.
ech nolog ies develop ed at J efferson during 1995- 96
spa nned a br oad ran ge of biom edi cal disciplines.
Pharmaceuticals wer e develop ed which may pr event or treat
major diseases, including multipl e sclerosis, rh eumatoid
arthritis, fibrosis, heart disease, cance r, AIDS, stroke and
malari a. Medica' devices we re develop ed for a variety of
applica tions , includi ng cathe ters for d iagnosi ng and treating
heart disease, sys tems for imp ro ving th e quality of x-ray
ma chines and othe r imagin g equ ipme n t, improved surgical
instrum ents as well as sys tems to help restore proper
fun cti oning o f th e heart and blood vessels, provide speech
and mobility, and repair skin and cartilage. Diagnostics were
devel op ed to provide earlier detection of so me d iseases.
Jefferson resear ch ers hav e devel op ed mor e se nsitive methods
to determ in e th e pr esen ce or ex tent o f prost ate, co lorectal ,
and cervica l cance r, smoo th mu scle tumors, AID ,
ort ho pae d ic in fections, and hepat itis B, as we ll as to localize
in terna l infectio us foci. Tumo r suppresso r genes whi ch playa
ro le in a number o f th e most freque n t types of cancer wer e
identifi ed , and wh ich may allow th e develop ment of new
treatments for cance r. Finally, reagent s we re developed 10
sto re and cultivate ce lls, including blood co mponen t for

continued Oil page 10
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he initi at ive s tarted during th e 1980s to streng the n and
increase th e resear ch effort at J efferson ha s resulted in an
investme nt in ou tsta ndi ng sc ient ific talent and mod ern
research faciliti es th at has enabled Jefferson to be recogni zed
n ow as a leading medi cal resear ch ce nte r. This resear ch
in itiativ e also has resulted in th e dev elopment of an infrastru cture at Jefferson whe re teams of recruited basic sc ient ists
with ou tstandi ng reputations co mpleme nt Jefferson 's acclaim ed
cli nicia ns . The result ing co llabo ra tion bet ween basic scient ists
an d clinicia ns ena bles J efferson to tak e resear ch breakthrou ghs
fro m th e lab oratory and quickl y translat e th em into pati ent
care ben efits , ln thi s da y and age , innovative clini cal research
performed at acade m ic medi cal ce nters mu st involve co llab ora tio n between basic scie nt ists a nd clinicians.
O ne part of th e co mpre he nsive plan env isioned by Dean
J oseph S. Go nne lla, M.D. to ens ure J efferson 's fu ture as a
lead ing acade m ic medi cal resear ch ce nter is to tak e ad vantage
of thi s new co llabo rative relati on ship by increasing th e amoun t
of clinical trial s ac tivity carried out at Jefferso n. The admi nistrati ve and sc ientific lead ership at J efferson is co m mitted to th e
ex pansion of cli nica l trials becau se th ey represent th e link
between resea rc h and pati ent care at J efferson. Assoc iated with
th is ini tiative is th e foste ring of innovativ e relation sh ips with
pr ivate sec to r orga n izations for th e ex p lora tion and evalua tion
of new co mpo u nds and devi ces to improve pati en t care.
T he strengtll of these new innovative relationships is built
on jeffe rson's ability to access ti,e large patient populations
necessary to conduct Phase III clinical trials tllmug/l its
partnerships s ucll as the j efferson Can cer Ne twork, ti,e
j efferson Healtll System, and ti,e Medical Cent er"of Delawar'e,
among others.
The first ste p in making a s treng the ne d clinical tria ls activity a
reality at Jefferson was to build th e cam pus infrastructure.
Dean Go nne lla chose Gerald Litwack , Ph .D. as th e architec t for
th is effort . Dr. Litwack, a not ed researche r in his ow n right ,
was Cha irma n of th e Dep artment of Pharm acology at th e tim e
of h is selec tio n. He is now Cha irma n o f th e newly co mbi ned
Dep artment of Bioch emi stry and Molecular Pharmacolo gy and
Assoc iate Dean for Scient ific Affairs. Dr. Litwack began by
restructuring th e former O ffice of Resear ch Ad min istra tio n
into a new entity , th e Office of Scient ific Affairs whose
major area s .of res ponsibi lity are l ) resea rch ad ministra tio n,
2) cli nica l trials, 3) corporate/i ndus trial relat ion s,
4) misconduct in research, 5) rese arch sa fety, and
6) gove rn me n t liaison .
9
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Resear ch ac tivity arisi ng ou t of a sc ien tific discover y, suc h as a
clini cal trial , is adm inis tere d by the Office of Scien tific Affairs .
Th e division o f Resea rch Ad mi nis tration in the Office of
Scientific Affairs signs off on all clinica l trials con tra cts. Th e
Institu tional Review Board (I RB) also co mes un d er th e
Resear ch Administrati on divi sion o f th e O ffice o f Scie ntific
Affairs. Th e IRB is charged with th e fed erall y mandated
resp on sibility for review of all pro to cols invo lvin g human
subjects. The Office of Scien tific Affairs wo rks closel y with th e
Office o f Technology Tr an sfer and wi th the Office of
Un iversity Co u nse l in arrang ing industri al co ntracts and
agreement s. Admi nistrati vely, th e Office of Scient ific Affairs is
part of th e medi cal co llege and reports to Dean Go nnella .
Becau se clinical trials were planned to be a major focus of th e
Office of Scien tific Affairs , Dr. Litwack selected Jo hn J .
Schrogie, M.D. , a clini cal ph arm acologist and found er and
CEO of th e Phil adelphia Assoc iation for Clinica l Trial s
( PACT) , to direct th e clini cal trials o ffice wi thin th e Office of
Scientific Affairs. T his office deals directl y with ph armaccutical co mpa nies , an sw ers th eir qu esti on s, addresses the ir
co nce rns , and becom es th eir facilit at or in inst itu ting clini cal
trials a t J efferson . Drs. Litwac k a nd Schrogie , together with
Tho mas Murray of th e Clin ical Tria ls Division , developed an
att rac tive handbook wh ich high lights J efferson 's ce nters of
exce lle nce and clinical faculty, th eir resear ch int erests, and
th eir past ex pe rience or pot ential ex pe rie nce in test ing new
drugs or devices with pati ents in cli n ica l se tt ings. This
handbook , which ex p lains th e depth a nd breadth of Jefferson 's
ex pe rtise and capa bilities in co nd ucting clinica l trials, was
mailed to 250 ph armaceutical co mpanies and co ntract
research organiza tions to enco urage th em to match the ir
needs with Jefferson's capable clinician s and basic scien tis ts.
ln addition , visits wer e mad e to acade mic institut ion s with
experience and success in co nduc ting clinica l trials in ord er to
learn fro m th eir mist ak es and from th eir successes. As Dr.
Litwack ex plai ns , th ese effo rts are a ma tter of educating th ese
co mpa nies ab out J efferson 's capab ilities in providing a site for
th eir clin ical trials, and th en bein g able to deliver caml ess
se rvice at co mpe titive rat es.
Additio na l space for resear ch facilities was secured by th e
recent j efferson purch ase of th e for mer We stern Un ion
Build ing at 11th and Locust Streets . Anot her piece of th e
clinica l research infrastr uc ture o n campus is th e new Clin ical
Resea rch Cen ter on th e 11th floor of th e Tho mpso n Building.
Th e center, under th e curren t directi on of Scott A. Wald man ,
De cember

1996

M.D., Ph .D. (see page 21), is an organiza tional co mpo ne nt of
the Department of Medicine and possesses the faciliti es and
staff to provide th e inp atient and outpatient resources needed
to accomplish clinica l trials. Representatives from co mpanies
interested in pursui ng clinica l trials whic h wo uld be
ap pro priate for th e Clinical Resear ch Cente r are given tours of
th e facilit y. If appro priate, th ey are th en put in touch wit h
interested faculty memb ers to develop a suitable protocol for
the proposed clinica l trial.
The clinica l trial s division at j efferson has been organized to
provide researc h spo nso rs with a single office for assistan ce in
iden tifying investigato rs whose clinica l tri al int erests,
experience, an d pat ients mat ch the stu dy require me nts of
their prot ocols. As Dr. Litwac k point s out, clini cal trial s now
are becoming a big bu sin ess in thi s co untry. It is difficult for
mos t medica l uni versities to be compe titive in attr acting
clinical tria ls because of th eir associated overhea d . Th e effort
put fort h to da te by j efferson to becom e mor e in volved with
clini cal trials has help ed th em becom e mor e compe titive in
this marketpl ace. Mos t of th e effort to date has been d irected
to contrac t research organiza tio ns and ph armaceutical
compa nies. A contrac t research organization is a pri vat e or
public clinical research organization that acts as a middle
ma n, a broker, or a clearing hou se in clini cal tri al activities .
They are used mainl y by phar mace utical compa nies to arrange
for clinical trials becau se th ey usu ally have goo d scient ific
contacts, and can se t up single-ce nter or multicenter tria ls.
They also monitor th e progress and conduc t of the clin ical
trial. egotiating with a single clinica l trials office, suc h as th e
one at jefferson, is an attrac tive ince n tive for cont rac t resea rch
organizations and ph armaceuti cal co mpa nies , particularl y
after th eir represent ati ves have been give n a tour of j efferson's
facilities and sense d jefferson's capab ilities.
Dr. Litwack explains how the clini cal trial pro cess works at
jefferso n. A prop osal for a clini cal trial is received by the
clinical trials office. The pro posa l details wha t th e spo nso ring
orga nization wants to acco mplish and spec ifies th e number
and type of patients needed for th e trial. Th e office of clini cal
trials ident ifies faculty clini cal resear ch ers whose interests
correspond wit h th e needs of th e prop osed trial and who may
be willing to pa rticipate. During the negotiati on pro cess, one
part icul ar faculty research er is identi fied by th e invo lved
department , or th e department cha irma n, as the Prin cipa l
Investi gator (P.I.) . The P.l. develops a budget for the prop osed
clinical tria l and submits it to th e prop osin g contrac t research
organiza tion or ph arm aceutical compa ny . Thi s budget also
includes all dir ect cos ts incurred by th e Investi gativ e Drug
Service , a func tion of the Pharm acy and a service that is useful
in many Phase I and Phase II clinica l trials. j efferson charges
25 percent of th e direct cos t of th e clini cal trial as its indi rec t
cos t. If th e su bmitte d budget is acce pted by th e spo nso ring
orga nization , the involved individua ls se t up th eir ow n
process and ini tiate th e clinica l trial after receivin g ap proval
from th e Institution al Review Board . After th e clini cal trial
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begins, the clinica l trials office has onl y a helping and adv isory
fun ction . Th e clinical trial inves tigators have th e responsibiliti es
of understanding th e tr eatm ent protocol of the clini cal trial , of
following th e clinica l trial guidelines faithfully, and of reporting
th e results of th e clinica l trial scrupulously.
Dr. Litwack believes th e clinical trials ini tiative is going well at
j efferson . He says th e office of clinica l tria ls often receives two
to th ree new prop osals per week. He explains that Phase I
clin ical trials test th e effects of new products on norm al peopl e
to look for possibl e toxic reactions, while Phase II and Phase 1Jl
clini cal trials test th e effects of new prod ucts on a class of
patient s with a specific disease or disorder. Budgets for Phase II
and Phase 1Jl clinica l trials usually provide a source of funding
for the involved clinical resear ch ers. While the details of
speci fic clini cal trials are confide ntial un til the tria l is
completed , Dr. Litwack says that the clinical trial s now ongo ing
at j efferson invo lve a wide variety of large and small ph arm aceutical co mpanies, and includ e suc h diseases and dis ord ers as
stro ke, AIDS, cancer, includi ng breast cancer, gastroin testinal
disord ers an d rhe umatoid art hritis. He points to a pile of
between 10 and 15 new clinica l tria l application s awaiting
pr esentation at th e next meeting of th e Inst itut ional
Review Board.
Th e mand ate give n to Dean Gonnella in 1982 to increase
j efferson's prominen ce in research and his comprehe nsive plan
to fulfill that mandat e appea r to have been successful. The fruit s
of this effort have spread j efferson's reputat ion worldwide, have
brou ght addi tio nal patients to jefferson, and have been a source
of additional fundi ng. During fiscal year 1996, in addition to
NIH research awa rds , j efferson received 12.5 million dollars
from corpo rate research funding and clinica l trials revenu e. Th e
alu mni can be assured that jefferson's future as a leading
acade mic medical center and as a medical college that gradua tes
goo d doctors with exce llent clinical ski lls now is brighter
becau se of th e organized and effective way th is research
initiative is being implem ent ed.

Te chnology Tra n sfe r , from page 8
tran spl antat ion . A varie ty of cells whi ch are useful for research
purposes also were developed .
Over the past two and one-half years , 10 new companies were
crea ted based on techno logies dev eloped at jefferson ; these are
co mpa nies in which the university has or will receive equ ity.
Twenty Ll.S, pat ents were issued to the university during fiscal
year 1996 , a 67 percent increase over fiscal year 1995. In 1995,
j efferson ranked 29 th of all U.S. universities in pat ents issu ed.
During fiscal yea r 1995-96 corporate support for university
research amo unted to 11.4 millio n do llars, in addition to 1.75
milli on dollars received from licensin g revenues. Viewed from
th e persp ective of 15 years, j efferson's decision to add a research
component to its acclaimed reputation for clini cal exce llence
can be judge d to have been a wise one .
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Jefferson Medical College Alumni Associ ation invites you to join a
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June 13-21, 1997
An educational getaway: enjoy the beauty of the Burgundy region of France by hotel barge
with fellow Jeffersonians. Hosted by William V. Harrer '62. past Alum ni President and
Professor of Pathology. General medical update topics will be presented by
faculty and alumni, led by Jerome J. Vernick '62, past Alum ni President.
Clinical Professor and Director of the Trauma Division
Friday. 6/13 A rrive in Paris
This evening, profe ssional
wine and food aut hority
Melba Mau viel will host a
"Harmo ny in Food and Wine"
dinner at a cha rming Parisian
restaurant. Thi s unique and
delightful "experience
gastro no mique " will pr epare
us for our cru ise through on e
of France 's most famou s win e
region s. Melba will join us
lat er in Burgundy to
acco mpany us to so me of her
favorite vineyards: Pornmard,
Meursault, uit s
St. Geo rges.
Saturday. 6/14 Travel in Firs t
Class on the TGV express
train to Dijo", disembarl:ing
f or hwdl Continue by motor
coach to our bar ge. Our
afternoon cru ise to
Lon gecourt-en -Plaine begins
with a champagne welcome.
Sunday. 6/15 Monr ing Cruise
to Lovel)' St. ]ean-de-Los"e
After th e morning cru ise to St.
j ean -de-Losn e we will driv e to
nearb y Dole for a walking
tour.
Monday. 6/16 To ur of Beaune
Th e river Saon e brings us to
Verdun-s u r-le-Doubs, where
we board a motor coach for
wo rld-famo us Beaune, capital
of Burgundy'S wine region.
After a tour of Beaune and its
15th-century hospi ces , we
return to the bar ge.

Tuesday. 6/17 Cruise to
Chalon-sur-Saone After a
morning cruise to Chalonsur-Saone, we embark on a
shore excursion to Dijon. A
tour shows us the historic
city cente r, with tim e to
browse in Burgundy'S largest
open market. Return to th e
barge for lunch and an
afternoon cruise to Chagny.
Wednesday. 6/ 18 Arriving at
Chagrl)' The heart of th e
Burgundian vin eyard s,
toda y's excursion shows us
th e area where 12th-century
monks first set up their
pr esses. We also visit a win e
wholesaler to tast e some local
vintages on tap .
Thursday. 6/19 St . Leger-surDheune (Cruising) We visi t
th e fortress of Rully , pri vat e
castle of the Comte d'Aviau
de Ternay. Back at the barg e,
we gather for a farewell
dinner tonight, our last on
board.

Rates

The rate of $3400/perso n includes: in Paris, two nights
lodging with buffet breakfasts and special win e tasting/dinner,
hotel tran sfer to train station, round-trip first-class TGV, ParisDijon , all transfers to and from barge, acco mmoda tions, breakfast,
three-course buffet lun ch es, four- to five-course dinners, all bar
drinks and unlimited win e with meals, morning coffee, afternoon
tea, all excursions and entry fees , use of bicycles while barging, all
taxes. Th e tour is organized and esco rted by Adri Peacock , Ph.D .
in Romanc e Langua ges and Frenc h, travel specialist since 1981.
Air tran sportation betw een u.s. and Paris is NOT included.
Round-trip airfare from Philadelphia depart ing june 12, 1997 will
be approximately $585.00. Comprehensive travel insurance is
recommend ed.

I) Reserve Now for the Tri p
Contact: Adri Peacock , Travel Specialist
Rout es de France Travel , Inc.
4839 Olm os Street, El Paso, TX 79922
915 -581-6913 or FAX 9 15-587 -5725
Reserve NOW. Spac e is limited. Deposit of $500 per person insures
your place on the barge. Balance of $2900 du e March 13, 1997.

2) Register Now
To register , mail the form below to: jM C Office of CME, Alumni
Trip, 1020 Locu st Street M-32 , Philadelphia, PA 19 107. Enclos e
),our registration f ee of $250.00 payabl e to ]MC Office of CME.
For que sti ons regarding Continuing Medica l Educa tion credits,
call thejMC Office of CME at 215-955-6992 or 1-888-j EFF-CME
or fax 215-923-3212.

~

Friday. 6120 TG Vexpress
bad: to Paris We connect
with TGV express back to
Paris , arriving earl y
afternoon. Overnight in
Paris.

Name

.
Class Year or Jeff Affiliation _ _

Guest Name

_

Preferred Address

Saturday. 6121 Bach to U.S.
An extra day in Paris can be
arranged for tho se wishing to
extend their French
experienc e.

City

_

Stare _ _ Zip

Daytime Pho ne

o Yes . I am willing to give a one- hour educational presentation.

Thomas
Jefferson
University

I

Jefferson
Me di cal
Coll ege

_
_

World-Class
Athlet
es
&
Rich ard Cohen '6 5 Officiate s at th e Oly m p ic s
J olin j. Ga rt/and 5'44
efferso n was rep resented ably during th e 199 6 Sum me r
Olympic Games in Atlan ta by Richard W . Co he n '65 who
serve d as Chai rma n o f the Doping Co n trol Program for thi s
Cen tennia l Olympiad . Th e int er esting story of how he achi eved
this res po nsible position for th e 1996 Su mme r Olym pic Ga mes
was shared wit h th e Bulletin.
After Jeffe rso n graduatio n, he comp leted an ortho paedic surgery
resid en cy at the Unive rsity of Penn sylvan ia, was board -cert ified ,
and in 1970 bega n an ort hopaedic an d spo rts med icine practice
in orristown, PA. Spurred by an interes t in orga nizatio na l
medicine and an inte rest in civic ac tivities sha red with his wife,
Dianne, the y bega n to consider th e possibility of relocating to
anot her area holdin g mor e prom ise of growth and offering mor e
oppo rtuni ties for fulfilling th eir othe r in terests. After a peri od of
de liberate s tudy, th ey selec ted Atlan ta, GA as th eir new hom e
and move d in 1972. Dr. Co he n joined a friend fro m '
Philadelph ia in practi ce in s ubur ban Atla nta and th e Co he n
family remain s conv ince d that th eir cho ice o f new hom e and
pract ice se tti ng was th e co rrec t one for th em .
As Dr. Co hen's ort ho pae dic pra cti ce grew, so did th e resp on sibiliti es thrust up on him by others. He se rved as Chief of Staff
and Chief o f O rt ho paed ics at Co bb Hospital and Medi cal
Center, and at the Kennesi on e Windhill Hospital, both in
subur ban Atlanta . He served as Presid ent o f th e Cobb Co un ty
Medica l Society and Vice Presid ent of the Medi cal Assoc iation of
Georgia. Curren tly, he is Vice Cha irma n of Geo rgia's delegati on
to the Ame rican Med ical Assoc iatio n and will cha ir th e
delegation in 1997. He is a past President of the Geo rgia
Chapter of th e Ame rica n J ewish Co m mi ttee and served as
Chairma n of the Physician Sect ion o f Un ited Way in 1988 .
His varied activi ties ou tside of his regular occ u pa tio n of
ort hopaed ics brought Dr. Co he n to th e atte ntion of Leadersh ip
Atlanta , whi ch he was invited to join in 1981 . Lead ersh ip
Atlanta is a ne twork of 2,000 selec ted peopl e with lead ership
quali ties betwee n the ages of 35 and 50 yea rs whose so le
purpose is to bett er th e life o f Atlanta . The gro up meets mon thl y
for an ent ire day to discu ss topi cs releva n t to life in Atlanta,
such as race rela tio ns, the j us tice sys tem, and th e medi a, amo ng
othe rs. Netwo rking within Lead ership Atlan ta provided th e
spar k, co mmitme nt, and key co n tacts which ultimatel y resulted
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in Atlanta's successful bid for the 1996 SLI mmer Olymp ic
Games . Dr. Co he n was appo inte d a member of th e Atlanta
Olym pic Organizing Co m mi ttee in 1988 , an appoi ntm ent which
signaled his o fficial co nnec tion with th e Olymp ic effort .
His real wo rk as a member of the Atlanta Olympi c Or gani zing
Co mmittee began after Atlanta was selected to represent th e
United States in the bid agai nst other com peting co un tries for
th e pr ivilege of hosting th e 1996 SLI mmer Olympi c Games. Dr.
Co he n chai red th e lcdi cal Commissio n within th e official Bid
Commi ttee for the 1996 Olym pic Games. Th e job of the Med ical
Commissio n was to develop the medi cal concept for the
Int ernati on al Olym pic Com mi ttee (lO C) bid which had to
incl ude details for provi di ng medi cal care for more than two
mill ion spec tato rs, 12,000 athletes, 70,000 su pport personnel ,
and 15,000 medi a personnel. The resp on sibilities not only
include d th e med ical care of both athle tes and spec tato rs and
medi cal ca re in th e Olympic Village , but also mechanism s for
gender verification and dop ing co n tro l of competing athletes.
Dr. Co he n was a member o f th e Atla n ta gro up sen t to Tok yo in
1990 for th e final site selec tion to be mad e by the In tern ational
Olympi c Co mmittee (l OC) betw een th e six finalists, Toronto ,
Belgrad e, Man ch ester , Eng land, Melbourn e, Australia , Athens,
and Atlanta . To th eir joy, Atlan ta was selected as the host o f the
1996 Sum me r Olympic Ga mes. Like th e 1984 Los Angeles
Su mme r Olympic Ga mes, Atlan ta's bid was privately fu nded.
Th e Ame rican TV rights, th e city's Sou the rn charm, and
Atlan ta's presumed ability to make the Games a finan cial
success are believed to have been important factors in Atlanta 's
selec tion. After th e joy of success came th e reali zati on that now
th e hard wo rk began for the Atlanta peopl e. After returning
from To kyo , Dr. Co he n was appointed Chairman o f the Th ird
IO C Wo rld Co ngress on Sports Sciences and Chairma n o f the
Dopi ng Co n tro l Program for the 1996 Olympi c Gam es, a
respo nsibility which wou ld still leave him some tim e for his
pr actice.
Dr. Co he n soo n learn ed that the sc ience of modern doping
co ntrol is based on ana lytical che mistry, an observati on that
necessitat ed brushing LIp on his kn owledge of biochemi stry. He
also learned that mos t mistak es in doping co ntro l occur during
th e tim e betw een athlete notifi cati on and u rin e collection and
D e c e mb e r
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Dr. Cohen on site at the Games
with David Apple. Co-Chairman

diureti cs , anabolic stero ids , and pept ide hormones. In additi on ,
Dr. Cohe n's committee rent ed three high -resolution mass
spec tro me ters whic h can not only ide ntify min ut e amounts of
stero id in a urin e sample, but also can ide nt ify traces of steroid
tak en months before. Use of thi s high-tech testing too l in
Atlanta was an Olympic firs t. The Doping Control Program 's
spec ific resp onsibility for the urine samp le ends wh en the
sample reach es th e laborat ory.

its transport to th e labor atory for examination . It becam e
evident to th e Dop ing Contro l Co mmittee that th e "chain of
cus tod y," or th e tracking of th e urine sa mple from th e manufacturer of th e samp le co llectio n kit , to th e notifi cati on of the
athlete, to th e collection of th e urine sample and its tran sp ort to
the laboratory, mu st be mad e totally sec ure to pr event mistak es.
In addition to employi ng a local bonded cour ier service for
transport of the ur ine sa mple to th e laborat ory, his committee
obtaine d special tamper-p roof co ntaine rs from England , mad e
especially for thi s purpose. The Dop ing Con tro l Program had to
deve lop its own laborat ory facilit ies in Atlant a, and also had to
identify local, nationa l, and int ern ati on al expe rts to assist in all
th e details of adequa te and effective dop ing control. .
Duri ng the Olympic Games , Dr. Co he n's Dop ing Con tro l
Program supervised a total of 23 different Doping Control
Stations and 450 volunteer personnel. Dr. Cohe n explains that
beca use of the way events are sc hed uled during th e Olympics,
only about 18 of th ese sta tio ns operated at any on e tim e. A
Dopi ng Contro l Station is whe re urine is co llected from the
at hletes and where th e "chain of cus tody" is most complicated.
Dr. Cohen says th ey test ed all medal winne rs and , randoml y,
abo ut one in four othe r athletes. Th ose housed in th e Olympi c
Village kn ew of th e po licy and were aware of th e possibi lity of
being tes ted . After eac h event , th e win ne rs have one hour in
whic h to repo rt to a Doping Contro l Station . Thi s grace period
gives the ath lete sufficient tim e to atte nd th e medal cer emony
and press co nfere nces. The "chain of cus tody" begin s at thi s
poin t becau se each medal wi nne r is chaperoned closely after th e
finish of the event by a Dop ing Cont rol Escort .

The res u lt of each ur ine examina tio n is reported wit hin 24
hours to the Int ernati on al Olympic Co mmittee (lOC) Medical
Commission . If th e test is positi ve for an y banned substance, the
athlete is informed and Sample B is th en exa mined as a verification chec k. If sample B is positive also , th e ath lete is informed
and given a cha nce to explain to the IOC Medical Commission
which has th e power to impose sanc tio ns. In past Olympi c
Games , some sanc tioned at hletes so ught injunctive relief from
sanctions by pleading to local cour ts. Th is never prov ed to be a
satisfactory solution for eithe r th e IOC or th e sancti oned athl ete
becau se of variability within cour t systems around th e world.
In 1994 th e IOC instituted a new meth od for appeals by se tting
up an Int ern ati onal Court of Arbitra tion whic h was used for the
first tim e during th e 1996 Games in Atlanta. In ord er to
compete in th e 1996 Games , eac h athlete had to sign an
agree me nt not to appea l a sanc tio n to a U.s. court but , rath er , to
take his appea l to th e new Int ernat ion al Court of Arbitration.
This new appeals pr ocess is a totally ind epend ent mechanism
with a main pan el of 150 lawyer arbiters from all over the
wo rld. Each appea ls pan el consis ts of three lawyer arbiters
dr awn from th e main pan el. Sanc tioned athletes appealing to
this new Court of Arbitra tion can expect a binding decision
within 24 hours.

Each Dop ing Contro l Statio n is staffed by a team of ph ysician s
and paramed ical personnel an d eac h urine collec tion is
observed by a sta ff perso n. After collec tion, th e urine sa mple is
split into two sa mples, A and B. Each is placed in a tamperproof conta iner and put int o a secure trans po rta tion bag. Local
bon ded cour iers deliver the sa mples to th e testing laboratory
ru n by the Smit h Kline Beecha m Clinical Lab oratory Service.
Urine sa mple A is then analyzed for stimulants, narcotic s,

Dr. Cohe n and his committee hope their efforts during the 1996
Olympic Gam es in Atlan ta will lead to a better doping control
syst em for future Olympics and for all organized competiti ons.
As Dr. Cohen explains, eac h country has its own Olympic
Fede ration which sets th e standa rds and guideli nes for Olympi c
participat ion in its own country. The n, for a single two-w eek
peri od during eac h Olympic Games , eac h int ern ational
fed eration fun ction s under IOC con tro l. Dr. Cohe n is hop eful
that th e 1996 Atlanta Olym pics were a step toward greater
coope ration among th e 26 different fed erat ions. Considerable
variety in standa rds and guide lines still persists among
compe ting coun tries and spo rts fed erations, at least as far as
doping contro l is conce rne d. Dr. Cohe n believes that the
different federation s may becom e convinced of the advantage of
adopting a bett er doping cont rol sys tem which is mor e
standardized as to details of collection , ana lysis, ancl san cti ons,
suc h as th e sys tem employed in Atlanta for the 1996 Summe r
Olympic Gam es.
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7Che Blakings
ofthe
cramp/eat l'husi[ian
j. Edward Ball '36
~li n ically

or iented ph ysicians, wh eth er th eir tim e be spen t in
"'" private practice or in clini cal teaching in th e halls of medical
acade me, come to identify certa in fellow ph ysicians who stand
out from the rest. They possess certa in qu aliti es and attributes
that com mand the resp ect and admiration of th eir colleagues.
For want of a bett er term , I have categorized th em as "compleat"
physicians, purposely usin g th e old spelling "compleat," after
Isaak Walto n's The Compleat Angler (1653).
The principal qualities th at cha racterize th e "compleat" ph ysician
may be defined and considere d under several headings:

A Permanent Student
A basic attribute of th e compleat ph ysician is rema ining for ever
a student. At th e very beginning of his caree r he appreciates that
being a stu dent does not end with gradua tion from medical
schoo l. Thus does he ins ure th at th e remarkable and neverending discoveries, the additions to and th e modi fications of
our sum total of kn owledge in th e bro ad field of medicin e will
not go unnoted by him .

Inquisitiveness
To assure th at he ind eed maintains his stude nt ro le, the
comp leat ph ysician is dri ven by an unquenchable inquisitiveness
and an insatiable curiosity. Always, as ph en om ena are
encountere d clinically or in th e laboratory, he is moved to ask,
why have th ese ph enom ena develop ed? How do th ey arise? By
what mec hanisms? He is fully aware that all of us command the
same serving men of who m Rudyard Kipling boast ed:
I keep six hon est serving men
(They taught me all I kn ew).
Their nam es are Wha t and Why and Wh en
And How and Wh ere and Wh o.

Alert to Gains from Serendipity
The compleat ph ysician does mor e than remain an inquisiti ve
stude nt. He is alert as well to ph en om ena that appear pu rely
by chance in the course of daily activities- pheno mena that he
was not purposely seeking. Th ese, too, aro use his curiosity and
invite his in terest in th eir origin, mechani sms, and significance.

Adaptedfro m the j oe Henry Coley '34 Lecture delivered by Dr .
Ber/I at]eff erson Medical College. Dr. Ball is Distin guished
Professor and past Cha irma n of Medicine at the University of
California, Irvine, School of Medicine.
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In a lett er written by Horace Wa lpole in 1754 to his friend ,
Horace Mann, Wa lpo le described how taken he was by a fairy
tale he had recen tly read titled "The Three Princes of
Serendip" (the ancient nam e of the land changed to "Ceylon"
and pr esently kn own as "Sri Lanka"). The princes were
distingui shed by th eir un cann y knack of un covering
interesting findings for which they were no t looking. Walpole
felt that this remark able capac ity and its potential deserved to
be inco rporated in so me way into th e English language. To
serve such a purpose, he suggested th e wo rd "serendipity."
Th is sugges tion was adopted and th e word is now a fixtur e in
our dictionaries and speec h.
The gains from serendipity have adde d important ly, not onl y
to th e depth and breadth of general kn owledge, but also to
human welfare. Two outstanding exa mp les are th e observations of von Mering and Minkowski and th ose of Fleming.
In th e late 1800s, littl e was kn own abo ut the function of the
pan creas. Two inves tigators, von Mering and Minkowski ,
so ught to shed so me light on this th rou gh a series of experiments testing th e influ ence of th e pancreas on various
ingest ed food subs tances. As part of th eir experimental
app roach , th ey surgically removed th e pancrea s in a series of
dogs with the int ent of determining what alterations occurred
in th e digestive process as a consequence of having no
pancreas. In a cha nce postop erative conversation with on e of
th e animal care takers, th e care taker offha ndedly commented
about th e terrible time he was having fending off flies that
would imm ediately swa rm aro und areas in the ground wh ere
th e dogs had just urinated. Von Merin g and Minkowski,
struc k by this, verified th e caretaker's observa tion . Suspecting
that it might be exp lained by th e presence of some substance
in th e urine of th ese dogs th at was attrac tive to flies, they
obtained urin e from the dogs and exa mined th e specimens.
Th e striking findin g th at emerge d was th e presence in th e
urine of large amo unts of sugar. Thus for the first time a
spec ific organ was ide nt ified as involved in sugar metabolism
and in so me way resp on sible for diabetes mellitu s. Out of this
serendipitous finding ultimately came th e identification of th e
pan creatic islets and th e extrac tion from th em of insulin.
Th e gain from serendipity made by the British microbiologist,
Alexande r Fleming, is likewise notable and exciting in its
genesis. In 1929, Fleming examined a culture he had
prepared of a viru lent bacterium . He was dismayed to find
that th e culture had been contamina ted by a mold whos e
overgrow th rendered th e culture of littl e value. J ust as he was
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about to discard it, however, he happened to note that
wherever the mold grew in abundance , there were no
evident bacterial colonies.
To find some explanation for this phenomenon, he harvested
the mold and prepared a pure culture of it in a broth
medium. He then inoculated the broth culture of the mold
with the bacterium that he was studying and found that
bacterial growth was markedly inhibited. This suggested to
him that some substance within the mold passed into the
broth culture and suppressed the growth of the virulent
bacteria. Since the class of the mold was "penicillium ," he
named the unidentified substance "penicillin ." Thus was
born the antimicrobial era in medicine.
I cannot conclude these remarks on the potential gains from
serendipity without quoting one of the pithy comments of
that great phrasemaker, Yogi Berra of baseball fame: "You
can observe a lot by just watching. " Yogi's expression
probably says it all.

Investigation
The compleat physician is not content to be merely an alert
observer. Inherent in the total makeup of such a person is a
meritorious passion to seek answers to the questions raised
by the phenomena he might purposely or purely by chance
observe. It is of little moment how simple or how minor the
investigative study he undertakes may be. Nor should the
investigative attempt be viewed as nonproductive if the
results are uninformative or non-contributory. Out of the
attempt itself there will be gains with a salubrious effect on
that physician's future approach to the management of his
patients.
The investigative effort will at the least provide a better
understanding of some of the principles of research . Among
these is recognition of the importance of appropriate
controls and the determination of what constitutes
"significant" differences. Also will come appreciation of the
enormous effort and time that is consumed in searching the
literature for previous or related reports, in maintaining
records, in assembling the data, in devising tables and
illustrative material, in writing the report, and in supplementing the data with properly arranged references.
If the study should involve a review of hospital records, the
physician will likel y be moved from the experience to be
more detailed thereafter in his own recorded depictions of
the clinical features in a given patient. And the frustrations
he may have experienced in trying to decipher written
records will be apt to make him more sensitive to writing
legibly. Engaging in an inve stigative effort will also make a
physician more restrained when ordering a medication or a
test ; he will be more inclined to make certain that the
information to be gained, or the benefit that may ensue
outweighs the attendant risks.
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It is a commonly held belief that research of any valu e

requires a fully equipped laboratory, sophisticated and
complex equipment, and a host of technicians with spec ial
skills and knowledge. To the contrary, simple, inexpensive,
extremely modest clinical research carried out entirely alon e,
without benefit of supporting personnel and sophisticated
equipment, may nevertheless contribute worthwhile
information.
Consider the example of William Beaumont , dubbed by
Osler the "backwoods physiologist. " Beaumont was an Army
surgeon stationed in 1822 at Fort Crawford, a remote post
along the upper Mississippi . It fell to him to car e for a
trapper named Alexis St. Martin who had accidentally fired
his rifle into his abdomen . Under Beaumont's patient car e, 51.
Martin recovered but was left with a fistulous opening in his
abdominal wall that communicated with the stomach and
through which the interior of the stomach could be seen.
Even though working alone , without previous experimental
experience, and devoid of the paraphernalia that an investi gator at that point in time would be expected to possess,
Beaumont nonetheless set about observing and testing the
digestive capacity of the stomach in St. Martin and carefully
recorded his numerous observations. He even aspirated th e
gastric juice and verified that it was acidic.
For years he compiled and recorded careful observations, but
refrained from submitting them for publication in a medical
journal for fear they would be rejected or ridiculed . Wh en he
was finally persuaded to allow them to be published, some
16 years after the accident, he almost immediately attained
international fame and won an honored and permanent place
in medical history.

Flexibility
A hallmark of current-day medicine is the remarkable
profusion of new evidence, new insight, new discoveries.
Because of them , physicians must maintain what may be
described as "intellectual flexibility. " They must possess
receptive minds , examining new data and findings criti cally
but being prepared, should these data prove convincin g, to
alter, modify, or even discard previously held concepts and
ideas. They must constantly rethink, reappraise , reevaluate,
or un-learn much of what they learned in medical school as
newer information may dictate. Walter B. Cannon, M.D., the
distinguished Harvard gastrointestinal physiologist,
expressed the need for intellectual flexibility in these well
stated words: "We dwell in a world which is not settled, not
stationary, not finally immobilized. Consequently, wisdom
counsels keeping our minds open and recipient, hospitable
to new views and fresh advances" (The Way of An
Investigator, 1945). We must avoid what John Stuart Mill
called "the deep slumber of a decided opinion." Josh
Billings (the pen name of a popular humorist of yesteryear)
also underscored the danger inherent in a frozen mind
or a fixed idea in one of his classical aphorisms: "it's not
December

1996

wha t we don 't kn ow th at gets us into trouble. It's wh at we
know that ain't so ."

Hun lli }
The compleat physician is charac terized by humility. He is th e
first to acknowledge that his diagnost ic and th erapeuti c
triumphs are no t entire ly of his own making. He is awa re and
appreciative of th e fact th at con tribu tions by others helped
make his own successes possibl e: th e microbi ologist who
identified the respo nsib le orga nism and assesse d its sensitivity
to vario us antibio tics; th e path ologist whose microscopi c
examination of tissu e revealed abn orm aliti es that established th e
natur e of the disease; the radi ologist wh ose int erpretation of
images provided insight int o th e extent and nature of th e
underlying disorder ; th e endoscopist wh o supplied visual
depiction s of dir ectly visualized lesion s as well as biopsi es that
aided diagnosis; and th e nursin g staff whose tend er and devoted
care contri buted eno rmous ly to th e pati ent's ultimate recovery.

Attitudes and Relationships with Patients
Tha t medicine is both a scie nce and an art and not a pure or an
exac t science soon becom es eviden t to all physic ians who are
clinica lly engaged. one appreciates this more, however , th an
the compleat physic ian. All the mod ern -day, sophis tica ted
diagnostic app roac hes notwithstanding, he does not abando n
the fundamenta ls of a carefully taken history with a reaso ned
clinical interpretation of the sympto ms , followed by a carefully
performed physica l examina tion. He does not succumb to the
current error of "five minutes of history and five days of
testi ng."
The compleat ph ysician is also mindful that certa in eleme nts ,
atti tudes , and feelings deeply influ en ce th e relat ion ship between
ph ysician and patient. Time and again he has noted that open
display of th ese feelin gs seems to contribu te mor e to th e wellbeing of his patient than do th e medicati on s he prescrib ed or
the various other th erapeuti c measures he may have employed.
Th ese basic emo tions and attitudes enco mpass "compassion,"
"concern," and "caring."
In the early part of th e present century, Francis Weld Peabody,
M.D., Professor of Medicine at Harvard , said in a discourse on
the care of the patient tha t "the secre t of th e care of th e patient
is in caring for the patient. " These wor ds sho uld be engraved on
the hearts of every physician as th ey certai nly are on th ose who
qualify as compleat ph ysicians.

Even the most recent of today's medical school graduates could
enter th is hom e-based scene, whip out a syringe filled with a
potent an tibiotic, inject the contents into the sick young girl, and
the n leave withou t so much as a consoling word to the
distraught pa ren ts, yet rest content that by the followi ng
morn ing the chance is great that the child will show
improvement. We re any physician to perform in this fash ion ,
however, he would , desp ite the superior effectiveness of his
treatm ent, be far surpassed in human qualities by the frus trated
ph ysician shown in the painting.
All too often ph ysicians must deal with situ ations in which
every thing cur ren tly kn own or availab le has been tried but
without success. Th e disord er from whic h the patient su ffers
pro gresses inexorabl y and a fatal ou tcome is inevitable. In such
situa tions, it does not suffice to simply pronounce the
imminence of a fatal outco me and with that to depart, leavin g
th e distressed family bewild ered and emo tionally torn . The tru e
and compleat ph ysician needs no remi nder that in such trying
circums tances he mu st in some way provide con solati on and
support even tho ugh he too is torment ed and emoti onall y
anguis hed .
Wha t may be th e best hu man compassion at su ch sad times is
illustrated in a little story that I came across som e time back. A
young mot her is anxiously awai ting the return of her son from
schoo l. W ith each passi ng minute she grows more and more
conce rne d . Finally, the young lad appears. Seeing at a glance that
he is uninj ured, she gives vent to her pent-up emotion s by
berating him for his tardiness. The lad looks at his moth er and
says , "J im's bik e bro ke down and I had to help him. " This
explanation only rekind les th e mot her's agita ted state: "Help
him ! How could you help him? You know no thing about fixing
bikes." Again th e youngs ter looks meekly at his mo th er and says:
"You're right , mom , I don 't kn ow how to fix a bike and I could n't
help Jim fix his. But, mom , I had to help him cry."
This is precisely wha t th e compleat ph ysician will att empt in
suc h emo tion-draining situa tions. He will try as well as he can to
conso le a troubl ed famil y and friends, and help them cry.
Inscrib ed on th e statue of Dr. Edward L. Trudeau, a pione er in
th e treatm ent of tu bercu losis, is a 15th-centu ry (or perhaps
earlier) folk saying. The last three words su ccin ctly express the
warmt h of th e compleat physician that I have been att empting to
describe: "To cure sometimes , to relieve often , to comfort
always."

The qui ntessential attri butes of "compassion" and "concern "
are po rtrayed in th e pai nti ng T he Doctor by Sir Luk e Fildes . The
scene is set in 189 1. It de picts a ph ysician , garbed in the dr ess of
tha t day, gazing intently at a very sick young girl who lies befor e
him on a makes hift bed . In th e background are a weeping
mother and a conso ling fath er. Strikingly capture d by th e artis t
are th e troubled emo tions churn ing within th e doctor:
compassio n and conce rn as he gazes at th e sick; frustration and
perh aps even anger at his inability to do an ything trul y effectiv e.

I hope th at my young colleagues-to-be will aspire to become
"compleat" ph ysicians. Shou ld you succeed, I would say to
th em , in incorporating into your every action those attribu tes
th at charac ter ize a ph ysician of this quality, then , at the end of
your caree r, you will have the rewarding satisfaction of kn owing
that your life in medicine was a noble one , a contributory one,
one that won for you th e love and apprec iation of your pat ient s
and the resp ect and admiration of your colleagues.
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Jefferson Health System and Mercy Health
Corporation Forge Major Alliance
ercy Health
Corpo ration of
Southeastern Pennsylvani a
and Jefferson Health System
have anno unce d plans to
form a com prehe ns ive
alliance . Plat o A. Marinak os,
Presid ent and Chief
Executive Officer of Merc y,
and Dou glas S. Peters,
President and CEO of
J efferson Health System,
signed a Mem orandum of
Unde rstanding betw een th e
two health care delivery
systems followin g approval
by their resp ective
gove rn ing board s. As a
result of this allian ce, Mercy
and J efferson will form a
new, int egrat ed , multiinstitution al health network
with broad geog raphic
cove rage of th e Delaware
Valley.

M

"Th rough this alliance ,
Mercy seeks to partner with
J efferson Health System to
en hance and strengthe n our
mission ," says Marinakos.
"Our collabo rative efforts
will build on Mercy's 80year health care traditi on as
well as J efferson 's lon gstanding commitme nt to the
health needs of the
community. Th is includes a
sha red commitme nt to serve
all, including th ose in th e
grea test need ."
Health care services offered
by Mercy and J efferson spa n
th e entire Delaware Valley.
This alliance will enhance
existing programs and
se rvices and crea te new joint
initi ati ves through a
sepa rate joint se rvices
organization in orde r to
meet th e health needs o f th e
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region. Alliance initiatives
include program
dev elopment in primary
care, am bulatory car e
centers, ph ysician networks,
hom e health, rehabilitation ,
behavioral health , lon g term
care, and managed care .
"Specifically, we will bring
togeth er th e com pleme ntary
resources of Merc y, whi ch
has its foundations in
community-based
ambulatory and acu te
hospital care services as well
as mana ged care exp erti se,
with th e primary , terti ary,
community, and acad emi c
strengths of Jefferson,"
explains Peters. "Drawing
on our expe rt ise and
kn owledge, we will meet th e
challenges faced by th e
health car e industry with
inn ovat ive pro gramming
so lu tions ."
Th e Mercy-jefferson alliance
will link two of th e larger
health care sys tems in th e
region including a network
of more than 2,700 hospital
beds and more than 3,000
ph ysicians. As Marinakos
explains, "The purpose of
th e alliance is to focus on a
vision of the future of health
care wh ere services are
delivered in very different
ways than th ey are toda y.
Toward that vision , we will
develop a bro ad ran ge of
joint services including
linking our respective hom e
health organizations to
create th e largest provider of
its kind in th e area,
establishing a wid e network
of ambulatory care centers,
int egrating our ph ysician
netw orks, in vesting in lon g-
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term care and chronic care ,
and realigning our acute
hospitals to face th e future
under managed care."
Additionally, it is th e
obje ctive of th e alliance to
resume an academic affiliation between Mercy and
Thomas Jefferson University
in su ppo rt of resid en cy
programs at Fitzgerald
Mercy and Misericordia
Hospitals. Mercy was a
major teaching affiliat e of
Jefferson from 1969 to 1991.
System assets will not be
merged , and individual
sys tem identities will be
maintained . Th e
Mem orandum of
Unde rstanding calls for
Mercy and Jefferson to
develop a definitive alliance
agreem ent by April 30,
1997 .
Peters explains, "The
stre ngths of Mercy and th e
Jefferson Health System
compleme nt one an other.
We are very pleased and
excited to have Mercy join
Jefferson as a major partner.
This alliance creates
trem endous depth of se rvice
and br oad coverage, offering
a complete continuum of
care to the Delaware Valley
region ."
"Mercy will continue to
pr eserve and expand th e
Catholic health care
mini stry of our spo nso rs,
th e Sisters of Mercy," says
Marinakos. "The Jefferson
Health System philosophy is
consistent with our mission
and values as an organization. Our cultures and
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styles are similar , and
J efferson shares our
commi tme nt to caring for
th e health needs of the
communi ty. Together we
will resp ond to the future of
health care in crea tive and
proactive ways ."

Schwartz Joins
Pediatric Faculty
lias
Schwa rtz,
M.D. has
been
appo inted
Director of
Medical
Resear ch in the Department
of Ped iat rics at J efferson
Medica l Co llege and the
duP ont Hospital for
Children in Wilmington, a
close affiliate of Jefferson. He
comes to Jeff from the
Children's Hospital of
Phil adelphia, where he was
Physician-in-C hief and
Chairma n of Pediatrics.

E

Dr. Schwa rtz has written
mor e than 200 papers on
blood disorders of children,
including th e gene tics and
treatm ent of hemoglobin
abn ormaliti es such as
th alassem ia and sickl e cell
disease. He has lectur ed
extens ively on ane mia,
bleeding and plat elet
disord ers, and th e molecular
biology of hereditary blood
abno rma lities . He is a past
Presid ent of th e American
Socie ty of Pediatric
Hem atology/On cology.

R

SEARCH

Partial Liouid Ventilation Helps
Premature Infants to Survive
eff physician s, in collaboration with pediatricians
from institution s across th e
United States, have d iscovered
that partial liquid vent ilatio n,
also kn own as perlluorocarbon associat ed gas
exc ha nge, leads to clin ical
improvem ent and survival in
some infants wh o were not
pr edi cted to surv ive du e to
respiratory distress synd ro me.
Th ese find ings appeared in
the September 11 issue of Tlv e
New England jo urnal of
Medicine.

J

Th e research builds up on
previous stud ies of th e
efficacy of liquid vent ilatio n,
which uses a perflubron liquid
called LiquiVent ® from
Alliance Pharmaceutical
Corp. , San Diego and Hoech st
Mari on Rou ssel. Th e odo rless ,
colorless , and biologically
inert che mical is used to
gent ly expand and oxyge nate
lun g air sacs of pr em ature
infants who are in respiratory
distress. By introducin g
LiquiVent ® via glass syringe
int o the infant's endo tracheal
tub e and keeping th e
substance oxyge na ted in th e
lungs with a vent ilator, th e
research team sho wed that
parti al liquid ventilation is as
effective in infants as it has
proven to be in animals.
"Liquid vent ilatio n mor e
naturally simulates th e fluidfilled condition of lungs
before birth," explained coauthor Jay Gree nspa n, M.D.,
Assoc iate Professor of
Pediatrics at J efferson .
Th e study focused on 13
pr em ature infants (ges tationa l
age 24 to 34 weeks; birth
weight 600 to 2000 gm) less
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than five days old with severe
respiratory distress syndrome
wh o had failed conve nt ional
th erapy including sur factant .
Infants were ineligibl e if th ey
had cond itions that would
int erfere with th e int erpretati on of ou tco mes or rend er
medical int ervention futil e.
Within one hour of
beginning partial liquid
ventilation , oxygenation
improve d and ches t
radi ographs revealed even
expans ion of th e lung air sacs.
Infants were weaned to gas
ventilation without complication. Eight of th e 13 infants
surv ived to at least 36 weeks
correc ted gestational age .
"The implica tions of th is
stu dy are far-reaching,"
comme nts Dr. Greenspan.
"We now have further
evide nce that partial liquid
ventilation with LiquiVent ®
is a safe, lifesaving option for
pr em ature infants wh o had
virt ually no cha nce of living
befor e th e adv ent of
respira tory th erapi es."
Dr. Green span's contributions
to thi s study follow years of
his and Jefferson's devotion to
stu dying liquid ventilation
and other respiratory
th erapies. Jefferson was the
firs t Philadelphia-area
hospital to offer extraco rporeal membrane
oxygenation (ECMO) , a
surgical bypass procedure
that uses a heart-lung
machine to oxyge na te and
circu late blood . Th ese
pr evious studies and
breakthroughs mak e Jefferson
an ideal primary site for an
up coming Phase II stu dy of
partial liquid ventilation.
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Plectin Protein Deficiency is a
Hereditary Basis for Muscular
Dystrophy with Epidermolysis Bullosa

R

esearchers from J efferson
Medi cal College, in collaboration with in vesti gators
from the United Kingdom ,
hav e clon ed and seque nce d a
gene which underli es a
subtype of epide rmo lysis
bullosa (EB), a seve re,
inh erited , blistering skin
disease, and whi ch is
assoc iated with late-on set
mu scul ar dyst rophy. These
findings were publish ed in th e
August 1 issu e of Nature
Gcnetics.
Th e findin gs sugges t th at a
defect or deficien cy in plectin,
on e of th e pr otein s in volved
in anchoring skin layers,
appears to underli e EB and
mu scular dystrophy.
According to j ouni j. Uitto ,
M.D., Ph .D., Cha irm an of
Dermatology and Cutaneous
Biology, th e study results are
significant becau se they
dem onstrat e that EB affects
mu scle in addition to the
layers of skin. Th e new
information will allow for
early dia gnosis of mu scul ar
dystrophy in in fants born
with skin blist ering as well as
pro vide DNA-based pr enatal
testing for the disea se.
Th e study focu sed on four
families with memb ers born
with EB and wh o lat er
develop ed muscu lar
dystrophy in the seco nd
decad e of life. At birth, these
pat ients we re noted to have
skin blist ers cha rac teristic of
EB. Years later they
complained of mu scle
weakness. Without scie ntific
evide nce, a relati onsh ip
between EB and mu scul ar

D e c e m b e r 1996

dystrophy could only be
considered coincident al.
"Our stu dy was design ed to
see if there was a connection
between epidermolysis
bullosa an d mu scular
dystrophy," explains Dr.
Uitto . "Stu dy results lead us
to believe that EB is a
warn ing sign of muscular
dystrophy in some peopl e
rath er than an unrelat ed
d isorder."
By studying pat ien ts wit h the
autoso mal recessiv e disord er
term ed epidermolysis
bullosa with mus cular
dyst rophy (EB-MD),
resear ch ers found that
plectin is abse nt in the se
people. The absence of
plectin sugge sts th at it is the
candida te gene/protein
system for EB-MD mutation
and led investigators to
clo ne and sequ ence the
human plcctin cD A.
As a res ult of th e resear ch
findin gs, wom en who have a
child with EB-MD are
eligible for prena tal testing
via cho rionic villi sampling
during the ninth week of
th eir subseque nt
pregnan cies.
The study was tru ly a
multinat ional effort , joining
th e talents ofJefferson
research ers and invest igators
from th e University of
Dun dee; St. John's Institute
of Derm atology, London ;
Quee n Mary and Westfield
College , London ; ICRF
Clare Hall Laboratories,
Hert for dsh irc: the University
continues at right

RESEARCH
"Gene Repair" Technology Corrects
Genetic Mutation Leading to Sickle Cell Anemia

R

esearchers at Tho mas
Jefferso n Universi ty have
de mo ns tra ted a new gene
repair technology that may
hold prom ise as a treatment
for sickle cell ane mia and
othe r diseases by corr ecting
the DNA mutation from
which th ey arise . In a
study publish ed in the
September 6 issu e of Science,
research ers led by Eric
Kmiec, Ph.D., Assoc iate
Professor of Bioc he mis try
and Molecul ar
Pharm acology, repo rt th e
use of th erap eutic seque nces
of genes, term ed
chimeraplasts, to correct th e
spec ific point mutati on that
causes sickle cell anemia.
Based up on thi s and othe r
research already underway,
th e inves tigators th eorize
th at chi mera plasty may one
day provide an effective
treatm ent for an arr ay of
diseases that have a similar
genetic basis as sic kle cell
disease.

EB,from left
of Marburg ; Citta University,
Cata nia; St. Luk e's Hospital,
Malta; Nagoya University;
and th e Vienna Biocenter,
Vienna .
Dr. Uitto 's contri bu tions to
this multinati on al effort
follow years of devoti on to
studying EB. In 1991 , he
help ed identi fy a co llagen
gene resp onsibl e for holding
skin togeth er and linked a
site on the gene to a form of
EB. This resea rch provided a
founda tion for th e EB-MD
study. ,.
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Th e team of scientists from
J efferson 's Kimm el Cance r
Center, Coo per Medi cal
Cente r (Camden, New
J ersey) , and Corne ll
University Schoo l of
Medi cin e introduced th e
chime raplasts int o blood
cells dr awn from a sickle cell
ane mia pati ent. Sickle cell
ane mia arises from a
heredit ary mutation in
th e p-globin gene.
Chime raplasty co rrec ted th e
mutation in up to 10 to 20
percent of th e blood cells in
th e sa mple; a level which
th e experts believe can
potentially alleviate painful
symptoms and help to
pr event th e sys temic organ
dam age cause d by th e
disease. Th e research ers
found that the frequ en cy of
correc tion in cell sam ples
was dep endent on th e
amo unt, or dose, of
chime ra plasts used .
"W ith thi s gene repair
technique, we hop e to
correc t the gene tic mutation
in human blood cells in
sufficient qu antities to fortify
th e population of norm al,
healthy blood cells in sic kle
cell an emi a pati ents and
red uce th e epis odes of pain
and orga n dam age," says Dr.
Kmiec. "In addition ,
chimeraplasty may represent
a promisin g new th erap euti c
technique to correc t kn own
mutation s that cause ot he r
gene tic diseases, suc h as
cystic fibrosis and Gauc her's
disease."
Fu ture clini cal studies to
evalua te the safety and
effectiveness of
chime raplasty in sickle cell

C o l l e ge
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pati ents would inv olve
drawing blood from a
pati ent and th en introducin g
chime ra plasts into th e
blood 's stem cells. Stem cells
are pr ecursors from whic h
th e bod y's red and white
blood cells arise . The
in vestigat ors th eor ize th at by
co rrec ting th e p-globin
mutati on in th ese early stage
cells, th e correc t DNA
seque nce will be expresse d
in all subseque nt blood cells.
Th erapy wo uld most likel y
conclude with imp lant ati on
of th e cor rec ted cells back
in to th e pati ent via a bon e
marro w tran spl ant.
him e~aplasty

C very Imp ortant

may be a

development in th e field of
gene th erapy, which is
divided in to two catego ries.
Th e first is kn own as gene
au gment ation . These drugs
compe nsa te for the disease
state by incorporating a
correc t copy of a gene int o a
diseased cell, whic h th en
expresses th e normal pr otein
and compe nsa tes for th e
deficien cy. The seco nd
category, which includes
chime raplasty, is kn own as
chromoso ma l targeting, or
gene cor rec tion . These dru gs
aim to correc t or elimina te a
given gene from within the
chro moso me of th e diseased
cell. "The ability of any
vector to tar get a single base
that is inco rrec t in a
particul ar gene is part icu larly cha llenging ," says Dr.
Kmiec. "But the effort is
essential becau se, if
achi eved , it will provide a
number of clini cal
ad vantages."
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One imp ort ant advantage is
that no extra DNA is
introduced in to the cell, so
th e gene may be correc ted
within th e contex t of its
norm al chromoso ma l
enviro nment. Also , gene
correc tion may requir e fewer
doses , or even only a Single
dose, until an adequa te
percent age of cells are
corrected . Finall y, an
immune respo nse to the drug
can be avoided since the gene
that is correc ted is a natural
compone nt of th e cell.
In sickle cell ane mia , th e
p-glob in gene mu tation leads
to th e pr odu ction of red
blood cells that are ba na naor sickle-shaped, and rigid in
th e presen ce of low oxyge n,
whereas normal red blood
cells are round and flexible.
The odd -shap ed cells may
becom e stuc k in the
capillaries, pile u p, and cu t
off blood flow to tissu es.
Ox ygen depriv ati on of tissu es
can lead to severe episodes of
pain , known as crises . In
add itio n, the misshapen cells
only live for abou t 20 days
and are dest royed whe n
trapp ed in the liver and
spleen. This results in
ane mia .
Sickle cell anemi a is th e most
commo n form of sickle cell
disease, and affects mor e than
50 ,000 Ameri can s. Most cases
occur amo ng AfricanAme ricans, although it is also
common amo ng persons of
Arabian , Caribbean, East
Indi an , Medit err an ean , and
South and Central Amer ican
descent. Abou t one in every
400 to 600 African- Americans
inh erits sickle cell disease.

RES E I

RCH

Genetic Discoveries Lead to New Tests for Lung Cancer
ancer resear ch ers led by
An tonio Giordan o , M.D.,
Ph.D ., of Jefferson 's Kimm el
Cance r Institute, believe that
dama ge to Rb-2lp 130, th e
hum an re tino blasto marelated gene, may lead to
lu ng cance r. Ciga re tte
smo ke , air pollution , so me
toxins breathed by wo rkers,
and othe r env iro n me nt al
carcinoge ns may cause the
dama ge and inhibit th e
body's ability to make the
pRb-2Ip130 protein , a
powerful tumor suppresso r
in human s and mammals.

C

The inves tigato rs are already
crea ting a new lung cance r
early detecti on and tumorgradi ng test to enable
ph ysician s to assess how
mu ch protein from Rb21p 130 is found in indi vidual
lun g cance r pati ents. Based
on th e results , clini cians may
begin treatments ear lier and
tailor them according to how
aggress ive th e cance r is. Th is
find ing , whic h appea red in
th e July issu e o f Clinical
Cancer Research, is th e lat est
for th e Jefferson team and
collaborato rs from th e
departments of ana to mic
path ology and respiratory
disease at th e Seco nd
Unive rsity of aples. The
work was fu nded primaril y
by th e ationa l Cance r
Institute ( CO.
"Dr. Giordano's findings
have the pot ential to red uce
mort alit y from lung cance r
significant ly," not es Dr.
Arthur C. Up to n , former
Director of th e CI and
President of the Ram azzin i
Institute. "By ide n tifying th e
molecul ar nature of th e
cha nges caus ing cancer in
cells of th e lun g, his findings
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may lead to tests for the early
detection of such changes and
to strategies for preventi ng
and for success fu lly trea ting
the disease."
Clinical application of the
resear ch ers' laboratory work,
and th e publicati on thi s
spring of Rb-2Ip130 studies in
three prominent medi cal
journals , mark an important
culmination point in the
study of the retinoblasto ma
gen e's involvem ent in cancer.
Dr. Giordano has been
studying th e gene for eigh t
years.
"Based on th e fact that Rb21p 130 protein levels
correspo nd with the stage of
lung can cer , a new test to
measure th e leve ls could be an
im mediat e benefit in
determining how aggr essive
cance r tumors are in
individual pat ients," says
Emanue l Rubin , M.D., the
Apo nte Professor and
Chairman of Pathology,
Anato my, and Cell Biology,
wh o is collabo rating with th e
research team on development
of the test.
In a pr eviou s paper in the
May 1 issu e of Cancer
Research, Dr. Giordano's team
identified th e gene named Rb2Ip130, locat ed on
chro mosome 16, and showed
that it mak es a protein that
plays a vital role in controlling
th e cell cycle in all human and
mammalian cells. When Rb21p130 is alt ered and can no t
produce its protein , pRb21p130, th e cell may not reach
th e natural s tage of
pr ogrammed cell death .
Instead, th e cell continues to
live and divid e ou t of co n tro l
possibl y leading to tumor
formation and cancer.
C ol l e g e A l umni
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In tests of various ca nce r cell
line s, wh en normal (wild
type) pRb-21p130 was
reintroduced back int o
can cerous cells, the protein
interacted with seve ral othe r
pr ot ein s, most not abl y one
nam ed cyc lin A, to block
uncontrolled cell growth by
moving th e cell along to th e
next stage in its natural life
cycle, whi ch even tua lly ends
in apoptosis. Without th e
critical tumor su ppresso r
gen e, th e cells cont in ued to
live and di vid e.
Th e scien tists next publish ed
th e complete 0 A mak eu p
of Rb-2Ip130 in th e May 15
issu e of Proceedings oj the
National Academy oj Sciences.
"Since we obse rved in th e lab
that a lack of pRb-2lp 130 may
playa critical rol e in
prolongin g cell life in a
variety of cance r types,
learning abo u t th e gene's
complete geno mic struc ture
and seque nce wo uld even
bett er ena ble us to
understand how pRb-2Ip 130
works so that we co uld focus
our efforts towards a clin ical
intervention in pati ents to
either pr event th em fro m
developing cance r, or to kill
can cer tu mo rs alrea dy
develop ed ," says Dr.
Giord an o.
practical oppo rtu nity to
apply this wo rk to the
diagn osti c realm of cance r
medi cin e soon aro se. In the
July issu e o f Clinical Cancer
Research, Dr. Giordano's
team descr ibed a study o f 77
tumor sa mples from male
and fema le pati ents with
surgically resec ted lu ng
cancer. Th ey found that the
less th e pRb-2Ip 130 pro tein is
expressed by a tumor , th e
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mor e aggressive th e lun g
cance r. In normal lung cells, a
high am ount o f pRb-21p130 is
pr esent. This da ta opens the
door to developing a vari ety of
tests agai nst the complete
path ogenesis of lun g cance r in
pa tients .
The first type of test sho uld be
wid ely available wi thin two
years. The tes t will accurately
describe which stage of
cance r, either I, u, Ill, or IV,
that ind ivid ual pati ents are in ,
base d upon the levels of pRb21p 130 th at are pr esent in
th eir excised lun g cancer
tumor. Treatments may then
be tailored accordingly.
Ano ther test type now being
inves tigated aims to anal yze
Rb-2Ip 130 in individuals to
determine gene tic susceptibilit y to lun g cancer.
Yet another type of test bein g
investigated will use the Rb21p 130 protein as a tumor
marker to learn wh en pati ent s
have deve loped lun g cancer.
"Using pRb-211' 130 as a tum or
mark er may be an efficient
meth od of co nti nuously
mon itori ng the group of
patients who is at the greatest
risk for lun g can cer before any
morphological changes have
occurred in th e lun g," says
Dr. Giordano. "In addition,
the ability to det ermine the
exac t level of pRb-2lp 130
ex press ion in individual lun g
ca ncer pat ients may be a
powerful progn ostic tool for
ph ysicians to aid th em in
de ter mining the most
appropriate treatment
strategy. ow that we
recognize an invers e
correlation between pRb21p130 expression and lun g
cance r stage , the questions

are : what levels of pRb-2I1'130
expressio n show cance r?
And wha t levels of pRb211'130 ex pressio n correlate
with each stage o f lun g
cancer? These answe rs will be
fou nd th rou gh a large-scale
screeni ng of pati ents."
Suc h a study is now
underway. Th e test , whi ch
will be a sur rogate to
histological grad ing by a
pathologist , is now under
development in a collaborati ve effort betw een
j efferson 's Departments of
Microb iology and
Immunology, and Pathology,
Ana tomy , and Cell Biology.
Ano the r impo rta nt
ap plica tion of a test for 1'Rb211'130 may be th e ability to
de termi ne earlier th an
previous ly possibl e susce p tibility in gro ups at risk for
lun g cance r, suc h as exsmo kers and worke rs wh o
have been ex pose d to
airbo rne carcinogens .
Fou ndry workers and peopl e
wh o live in highl y industrialized areas often br eathe
high levels of combus tion
products, including
carcinoge ns known as
polycyclic aromatic
hyd rocarb on s, whi ch have
been linked to lun g cance r.
Th e Ram azzini Institute for
Occ u pationa l and
Enviro nme nta l Health
Research is a lon gtime
suppo rte r of Dr. Giorda no 's
research . The institute is a
nonprofit orga nizatio n that
prom ot es and coo rdi na tes
multinati on al resear ch and
ed uca tio n.
Shel do n W . Samue ls, Vice
Presid ent for Policy Stu dies
continues at right
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Selective Marker for Metastatic Colorectal Tumors
Will Bring New Methods of Diagnosis
esearche rs at jefferson
have discover ed that th e
protein gua nylyl cyclase C
(GCC) is ex presse d in humans
so lely in the int estines,
including the colon and
rectum , making it a selectiv e
mark er for colorec tal tumors
that meta sta size outside th e
int estines. These findings
appear in the December 10
issu e of Proceedings oj the
National Academy oj Sciences.
Th e resear ch , led by Scott A.
Waldman , M.D., Ph.D. (see
page nin e) , Associate
Professor of Medi cin e and
Acting Director of th e Division
of Clinical Pharmacology,
is gro u ndbreaking becau se
it has th e pot ential to lead to
th e first effective way of
detecting co lorec tal tumors
once th ey migrate ou t of th e
int estines.

of th e Ramazzini Institute
and form er chair of the
Committee on Cancer Risk
Assessment of the National
Cancer Advisory Board ,
says, "Dr. Giordano's
discovery may have a
profound impact on the
assessme n t of ca ncercaus ing agents in the
enviro nme nt , by enabling
regulators to measure risks
to populations and
indi viduals from spec ific
doses of gene -damagi ng
age n ts at th e first stage of
cance r development."
This is th e seco nd gene thi s
yea r that has been linked to
th e development of lun g
cance r by resear ch ers at
jefferson's Kimmel Can cer
Institute.
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"The survival rat e for pati ents
wh o have meta stat ic
colorec tal cance r is pr esently
very poor , with only five
percent su rviving after five
years, becau se ther e has not
been an effecti ve way of
tracking its spread to othe r
organs and pr esent
chemotherapy do es not mak e
an enormous impact ,"
explains Dr. Waldman.
"Knowing that GC C is
specific to th e int estines
allows us to use it as a tag or
marker to det ect wh ere th e
cance r has sp read."
By exa mining human tissu e
samples with the reverse
transcription-polym era se
chain reaction (RT- PCR),
resear ch ers discover ed th at
GCC is only ex presse d by two
different cells in th e bod y. It
is pr esent in th e si ng le layer
of cells that lin es th e normal
intestine and co ntin ues to be
expressed after these cells
undergo mali gnant transformation and migrate out of th e
intestines into oth er sites. As
a result of thi s, GCC acts as a
marker , demarcating th e
cancer's sp read through out
th e bod y.
GCC is also th e recept or for
the heat-stabl e en tero toxin
(ST) produced by E. coli.
With this working
kn owledge, th e j efferson
team exposed pr eparati on s of
human tissu es to ST and
discovered that th e only
tissu es that int era ct with thi s
small pr ot ein were those th at
ex presse d GCc. Only tissu es
ou tside th e intestine,
containing metastati c
co lorec tal cance r, exp resse d
GeC and interacted with ST.
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"We found that ST effectively
bi nds to GCC in all tissu es
whic h contained metastatic
co lorec tal cancer, regardless
o f the type of tissue or its
locati on ," says Dr. Waldman.
"It is our hope that this
research leads to new
treatments that use ST as a
guided missile to guide
cance r-fighting poisons
directl y to metastat ic tumor
cells, without harm ing normal
s u rro u ndi ng tissu es."
Ta rge ted Diagn ostics and
The rape utics , Inc., a biot echnology com pany which has
acq uired the worldwide
exclusive license to the work
from Dr. Wa ldman's
laboratory, is laying the
gro u ndwo rk for the birth of
new diagn ost ic and
th erap eu tic op tion s by
developi ng a tissue biop sy test
th at will accurately stage
pat ients , to determine if
colorec tal cancer has spread
ou tside the in tes tine . Th e
company is also developing a
blood test that will determi ne
if colorec tal cancer has spread
beyond the int estine or has
recurred after definitive
surge ry. In add ition , work has
begun on new therapeu tics
which will use ST to tar get
and kill metastat ic colorectal
ca ncer cells.
"It is our goal to mak e
diagn ost ic tests available for
clinica l use in th e next two to
th ree years, reducing the
number of lives color ectal
cance r clai ms each year ,
which is current ly close to
50 ,000 ," says Har ry A. Arena ,
C.P.A., ~l. B .A., President and
CEO of Targeted Diagnostic s
and The rapeu tics , Inc.

RESEARCH
HIV-I Integrase Can Be Targeted for Gene Therapy
esea rch ers in th e
Division of Infectious
Diseases have made two more
imp ort ant discoveries about
th e human immuno defic iency
virus (HIV).

R

HIV- I Envelope Has
Penneable Pores

Research ers have discovered
that indi vidual, bioch emi cally
active HIV-l viruses have
perm eabl e por es that mak e
th e HIV-I envelope
vulne rable to cert ain
com pounds designed to kill
the virus . Th ese findin gs we re
publish ed in Proceedings of the
National Academy of Sciences.
The research , led by Roger J .
Pom erantz, M.D., Professor of
Medicin e, Chief of th e
Division of Infectious
Diseases, and Director of th e
Cente r for Human
Retro virology, and Hui Zhang,
M.D., Ph.D., research
assoc iate, is gro undbrea king

becau se it dem onstrates that
contrary to pr evious thought ,
th e HIV-l envelope is "open,"
allowing researchers to target
and kill each individual virus
with a group of com po unds
called nucleosid e an alog
triphosphates.
"These compounds have th e
ability to pen etrate th e viral
envelope, incorporate int o
and dir ectly terminat e th e life
of th e virus, " explains Dr.
Pom erantz. "As a result, viral
infectivity is potentl y
inhibited ."
Dem on strating th ese newlyfound cha racteristics of th e
viral enve lope has led
Jefferson resear ch ers to
pr op ose that nucleosid e
analog triphosphates might
also dir ectly act as viruc idal
agents that might be quite
useful in pre venting eithe r
heterosexu al and / or
hom osexual transmi ssion of
HIV-l. Th ese viruc ida l agents

could be coadministered with
spermicida l agent s. Instead of
onl y killing sperm, thi s
formula would also kill th e
individual HIV-1 viruses
befor e th ey becam e infectiou s.
"It is important to rem emb er ,
ho wever , that whil e thi s
finding is extreme ly enco uragin g, it is not a cure for
HIV-l or AIDS," says Dr.
Pom erantz. "In the sho rt term
it is our goal to use findings
such as th ese to change AIDS
from an acute disease to a
chroni c, treatable one. "

HIV-l IJIlegras e Can Be
Ta rge ted for Gene Therapy

Jefferson scientists have
discovered that intracellul ar
immunized cells have th e
potential to inhibit th e
pro gression of th e HIV-1 life
cycle wh en used as th erapy
during int egrase, th e period of
productive viral repli cati on.
The se findin gs appea r in th e

Decem ber issue of the j ouruui
of Virology.
The research , led by Dr.
Pom erantz and Drs. Lingxun
Duan and Pnin a Levy-Mintz , is
gro undbrea king because it is
one of the first time that the
integrase area of th e viral life
cycle has been targeted for
therap eut ic treatment.
Int egrase had been the most
d ifficult , and is a most
important, stage of HIV- I to
target wit h therapy.
"Being able to target int egrase
molecul es, those that carry
HIV-I DNA into host cell
DNA, can ultimately prevent
the HIV-1 virus from spreading
to new cells in pati ent s already
infected with the virus ,"
ex plains Dr. Pome rantz.
This is the begin ning of gene
th erapy research at Jefferson
for treatin g HIV-I infection . It
brings basic science from the
ben ch to the bed side . ,.

Less Radical Treatment May Eliminate Breast Cancer
study of women with in
situ (no ninvas ive) ductal
br east cance r revea ls that
excision and surve illance
alone are an alte rna tive to
mastectom y or irr adi ati on in
treatin g noninvasive br east
cancer. Results of th e stu dy
were pr esent ed at th e 32 nd
An nual Meeting of th e
Ame rican Society of Clinical
Onco logy .

A

mean and median follow-up
of 55 and 53 months, respectively.
During that tim e, only five of
th e 194 br easts in 191
wom en , or three percent of
the recurren ces sho wed
evide nce of invasive (o r lifethreat ening) cance r,
including microinvasion .
Twenty-three recurren ces
we re entirely noninvasive.

in mo st othe r studies to dat e.
"No patient in thi s gro u p has
died from breast cance r since
the study began ," he
explains. "Even if recurren ce
do es tak e place, it is most
likel y to be th e same type of
noninvasive cells as th e firs t
tim e. And in selected cases , a
seco nd, local exc isio n may be
suitable instead of irra dia tio n
or mast ectom y."

The data , collected betw een
1975 and 1994 at J efferson
Medical College , shows th at
only 28 of 194 breasts (three
wo me n had bilateral in situ
cancer) treat ed with excis ion
and surveillance alone had a
recurren ce. Th ere was a

According to se nior aut ho r
and pr esent er Gordon F.
Schwartz, M.D., M.B.A.,
Professor of Surgery at
Jefferson and a spec ialist in
diseases of th e br east , th ese
findings are contrary to th ose

Wom en with a confirmed
d iagnosis of noninvasive
br east cance r underwent
post-biopsy mammography
to verify excision of calcification s. Wide, local re-excision
was performed in most
pati ent s. The maximum
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diam eter of calcificati on s
cons ide red sui table for thi s
treatm ent option was 2.5 em .
"Excision and surveillan ce is
a reaso nable alternative to
mastectom y or irradiation for
selecte d women with in situ,
du ctal br east cancer that
pr esents nonpalpable calcifications, or as an incidental
finding ," says Dr. Schwartz.
"A major treat men t
reco mme nda tion su ch as
radiation or mastectomy may
be withheld un til and if a
recurrence does tak e place."
Dr. Schwa rtz notes that even
if a recu rren ce doe s occur, it
is likely to be noninvasive.

Melanoma Vaccine Clinical Trial
Shows Significant Improvement
in Four-Year Survival
nt erim results from a
clinical trial of a vaccine for
treating melan om a, led by
David A. Berd '68 of
j efferson's Division of
eoplastic Diseases, show
significant improvem ent in
four-year surv ival compared
to cur rently available
treatm ent s.

I

According to th e stu dy, whi ch
will be partially disclosed on
May 21 at th e annual meet ing
of th e America n Socie ty of
Clinica l Onco logy, 62 patients
were treated with a special
vaccine mad e up in part of
their own tum or cells. Fouryear survival was high er than
a control gro up of pati ents
treated with standa rd surgery ,
and higher than pati ents wh o
recently parti cip ated in
studies of th e drug alpha
inte rfero n.
The vacci ne under in vesti gation is bein g used
postsurgically for treating
advan ced , but surgically
resectabl e, malignant
melan oma . In th e study,
patient s with stage- Ill tumors
in the lymph nod es we re
trea ted with th e vacci ne after
standa rd lymphad en ectomyan operation whe re the
melan oma and surrounding
lymph nod es are rem oved . Of
62 pati ent s wh o received th e
vaccine , 47 percent were free
of relapse after four years, and
58 percent surv ived four
years. This is compared to 20
to 25 percent survival in
patient s treat ed with surgery
alone .
"The melan om a vaccin e is
n1ad e from a pati ent 's own
23
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tumor cells, which are
ina ctivated and modified with
th e che mical hapten dinitrophenyl. This pro cess makes
th e tumor cells appear foreign
to the pati ent's immune
sys tem, and so th e immune
sys tem atta cks and kills the
cells," explains Dr. Berd. The
pati ents also receive a low
dose of cyclophosphamide, a
medi cation co mmonly used in
cance r che mothe rapy, but
which has been shown to
boost th e immune sys tem
wh en administered in th e
right way.
An unexpected finding was
th e significantly better
sur vival of older patients in
th e study. The four- year
survival of patients over 50
years old was 66 percent ,
compared to 46 percent for
pati ents under 50 .
Dr. Berd is also researching
th e application of this type of
vaccine again st other
carcinomas, such as br east
cance r, colon cancer, and
ovarian canc er. These studies
are sched uled to begin in
abo ut one year.
In recent years, mortality from
melanoma has been
increasin g. In 1995 , th e
National Can cer Institute
(NCO expected more than
34,000 new individual cases
of melanoma in th e Unit ed
States alone , and expec ted
almos t 7,200 ind ividuals to
die from th e disease. Th e
in cid en ce has increased nearl y
80 percent betw een 1973 and
1987, at a rat e of approximat ely four percent per year,
according to the NCI. II)
C ol l e g e A l u mni
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Research
Funding Keeps
Growing

Linear Accelerator
for Radiosurgery
at Wills Eye

efferson receiv ed a tot al of
$75.2 milli on in Federal
and non -Federal resear ch
awards during fiscal year
1996 , up from $72.1 million
in fiscal year 1995 . In 1995
it ranked 36th am on g the
124 medical schools in th e
United States in term s of
research funding from th e
National Institutes of
Health . II)

hysicians at the
eurosensory Institut e,
W ills Eye Hospital, who hold
faculty appointmen ts at
j efferson Medical College,
are perform ing brain surgery
with a new device : a linear
acce lerato r spec ially
design ed for stereotactic
radi osurgery to the brain .
With this tech nology they
are treatin g bot h benign and
malign ant brain tum ors,
arte riove nous malformation s, and intracranial
disord ers, non invasively and
on an out pa tient basis.

J

Critical Care
Trials Group is
Funded by NIH
efferson is on e of 10
clini cal sites nati onwide
selected to participat e in th e
Criti cal Care Tri als Group
fund ed by th e ational
Institutes of Health. "This
marks th e first tim e th e NIH
has support ed a coordinated
group of acad emi c centers to
desi gn and carry out clinical
trials in th e area s of acut e
respiratory failur e, se psis,
and critical car e," acco rd ing
to jonathan Gottlieb , M.D.,
eo-princip al investi gator and
Associat e Professor of
Pulmonary Medicine and
Critical Car e. "As part of the
Critical Car e Trial s Group ,
we ha ve th e opportunity to
offer our pati ents parti cipati on in th e most adva nce d
treatment protocols, as well
as to enha nce our state of
kn owledge." IQ

J
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Assoc iate Professor of
Neurosurgery David W.
Andrews, M.D. explains that
th e new stereo tactic
treatm ent sys tem delivers
focused rad iation in eith er a
single dose, or in multiple
fractio ns over a per iod of
days. In either case, th e
patient usu ally returns to his
normal routine within days
and is spared the surgical
trauma and side effects
associat ed with open brain
surge ry.

STUDEN

Ar'TIVITIES

Alumni Too Can Participate in JeffHOPE
effHOPE, the stude nt-ru n
homel ess clini c and urban
health care pr oject w hich
was featured in th e June
1996 Bulletin, welco mes th e
par ticipation of Jefferson
gradua tes as we ll as
students.

J

What Does
j efjHOPE Do?
V provides free, accessibl e
medical care to medi cally
underserved indi vidu als in
Philad elphi a
V provides socia l se rvice
information and co unse ling
to patients at th e clinic sites
V helps J efferson stu de nts,
staff, faculty, and alumni to
educate th emselves about
the health probl ems and
socia l service needs of th e
homeless and med ically
underserved , and th e
broader soc ioeco no mic
issues related to "health"
V cond uc ts research int o
the health status and health
needs o f th e populati on s
JeffHOPE serves
V teach es formerl y
hom eless patients abo ut th e
health care sys tem, health
maint enan ce, violence
preventi on , and stress
man agem ent

V gives stude nts an
oppo rt unity to pra ctice
their histo ry-taking,
physical exam, and different ial diagn osis skills while
providing service to th e
community

What Does
jefjHOPE Need?
v Time
JeffHOPE runs on th e
volunteer tim e of stude nts
and ph ysician s. We need
local prima ry care
physicians to se rve as
pr eceptors at th e clinics, and
specialists in Philadelphia
who are willing to accept a
limited number of referrals
from th e clinics on a pro
bon o basis.

v Supplies
The clinics are supplied by
donation s from Th oma s
J effers on University, drug
companies, and pri vate
ph ysician pra ctic es. Th e
clinics need samples of
commo nly used drugs,
dr essing su pplies, office
equipme nt suc h as exa m
tabl es , blood pr essure cu ffs,
and othe r med ical su pplies.

V Financial Support
J effHOP E is a voluntee r
organizatio n. Th e expansio n
of its services and opportuniti es has created an
expa nsio n in its op erating
budget. Funds are needed to
suppo rt its se rvice learning
program , to cont inue its
lecture series, to improve its
pati ent educa tion pro gram ,
and to pro vid e administrative
suppo rt.
If you would like to help
J effHOP E to maintain its
successes and expand
its hor izon s, please call th e
J effHOPE office at
215955 18 78 .
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JeffHOP E (Health
Opportunities, Preventi on ,
and Edu cation) provides
compreh en sive health care
through weekl y clini cs at
shelte rs and service sites for
underserved men , wo me n ,
and children in Phil ad elphia.
Since January 1993, J effHOP E
voluntee rs have been
operating a pr ima ry health
car e clini c at St. Columba's
shelter for homeless men . In
Novemb er 1993, th e
volunteers established an
addition al clin ic at Gateway
Service Center, a city shelter
and day program. A th ird
shelter site ope ned in
September 1996 at a needl e
exc hange pro gram site run
by Prevention Point
Philadelphia. Unde r cons ide ration is a fourth sit e whi ch
would serve hom eless and
ment ally ill wom en in
Philadelphia.
All th e clinics are staffed by
voluntee r ph ysician s,
resid ents , med ical stu de nts,
nurses , nursin g stude nts, and
occupational and ph ysical
therapists. Th ey work
togeth er as a team to provide
health care for the poor and
underserved men and wo me n
of Cent er City. Each wee k,
ph ysician s, allied health
profession als, and stu de nts
pro vide desp erately needed
health care at each of th e sites,
treating probl ems ran ging
from skin problems to
congesti ve heart failur e.
By redu cin g barri ers to health
care and helping th ese men ,
wo me n , and child ren to
achieve bett er health ,
J effHOP E is helping th em to
return to main str eam soc iety
and to find housin g,
edu cati on , and employme nt.

D e c em b er
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In addi tion ,JeffHOPE
ope rates a pat ient education
pro gram in conjunc tion with
th e Grea ter Philadelphia
Urba n Affairs Coalition's job
training program for the
ho meless, and an educational
series for the Jefferson
com mu nity consisting of
speakers, discussion groups,
plays, and movies related to
issues of socia l responsibility
and medi cal services for the
urban underserved .
J effHO PE is active in
commu nity and epidemiologic
resea rch, with past and
cur rent projects including an
HIV and tuberculosis
prevalence study; investi gation into the demographic
characteristics of the
population th e clinics serve;
and research into parenting
and stress amo ng addicted
wo me n. The organization is
also active in curricular issues ,
and last spring instituted a
service/learning program in
whic h five first- or secondyear med ical students are
placed in com muni ty organizations for approxima tely 10
hours per week to assist with
program develop ment and
imp leme ntation .
J effHO PE has become a model
for medical schoo ls around
th e country. Health professio nal students and even
resident s volu nteer at
J effHOP E because it provides
th em oppo rtu nities for
learn ing and service to the
community which are
provided by no other part of
th eir ed ucation . Students from
ot her medical schools who are
orga nizing their own
hom eless shelter clinic project
visi t to learn from JeffHOPE
successes.

Student AMA Organizes
Bone Marrow Drive
Grego ry Gertner, Class oj 2000

n the cove r of a pamphle t

Ofrom th e Nationa l Marrow
Don or Program (N MDP), a
young child's eyes grab th e
reader's attentio n. Unde rnea th
the picture are th e word s, "I
need a marrow transpl ant. Please
Help." The jefferson Medical
College chapter of th e Ame rican
Medical Associati on is tryin g to
help . This year, the AMA plans
to conduc t its first annua l Bone
Marrow Registration Drive . But
they need your help as well.
An estimated 30,000 child ren
and adults in th e u.s. arc
diagn osed each year with
leuk emia, apla stic ane mia, or any
of ove r 60 othe r pot enti ally fatal
blood diseases. For man y, the
onl y hop e for sur vival is a
marrow tran sp lant. Thirty
percent of these pati ent s will
match marrow types with a
famil y memb er . This means that
70 percent of marrow tran splants
come from unrelated don ors,
and the only way to becom e an
unrelated don or is to regist er
with th e MOP. Unfortu nately,
there is a significant cos t to
register , and , espec ially at the
medical college level, students
who may be willin g to become
registered with th e NMDP are

unable to because they simply
cannot afford it. Th e NMDP ,
however , has found a corporate
donor wh o will match an y fund s
raised. This means that an y
donation s from you will help
twice as man y students becom e
registered with the Marrow
Don or Program .
In 1995, the NMDP coordinated
mo re than 80 tra nsp lan ts every
month . The program cou ld
accomplish even more if its
regist ry of volunteer donors
were larger and more diverse.
There may be so mebody hcre
at j efferson wh o has a marrow
type mat ching that of a dying
child . Thi s person needs your
help to becom e regist ered with
the NMDP. Your donation may
allow a medical student to save
a life now , before he or sh e even
become s a ph ysician.
th e AMA save lives in this way,
please send co rres po nde nce to
jefferson American Medical
Association, Medical Stud ent
Section, Attenti on : Steven
Sarkisian, President, 1000
Wa lnut St., Apt. 2007 ,
Philade lphia , PA 191 07. JI

V 223 first-year students mat ricul at ed th is fall at j efferson
Medical Co llege (340 we re acce p ted ou t of 11,189 applica nts)

V 71 are fem ale, and 152 are male
V eigh t are members of m inor iti es
V 25 already hold mast er's degr ees, a nd six hold doct orat es
V 22 are part of th e DIMER program for st ude nts from
Delaware (see article at rig ht )

V 21 are in the six-year acce lerated B.S.IM.D. program with
Pennsylvania State Un iversity

V 12 are particip at in g in th e Ph ysician Sho rtage Area Program
wh ich funnels-graduat es to practi ce in u nderserved areas
I EFF ER SON
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Daniel P. Petr o '2000 (right) and his sisler Anastasia. a member of
the Class of '99 (second from left). with their paren ts Paul and
Mal)' Petra at the Reception for Freshman Families on August 21

First-y ear leannlne A.
Weimar-Fitzpatrick
and her mother
Grace Wcimar

If you are int erested in helping

Jeff Physicians in the Year 2000
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Freshman st ude nts Gregory S. Gertner. Ryan I. Zlupko,
Anne M. Nelson. Kcvin I. Hira kawa, Omar K. Yunis
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Jefferson is Reconfirmed as
Delaware's Medical School
Delaware bill Signed into
law in July reconfirms
Jefferson's role as the medi cal
coll ege for the state of
Delaware.

A

Thro ug h th e Delaware
Inst itu te of Medical Education
and Research (D lMER ) ,
admission to Jefferson is
reserved each year for
students from Delaware.
The arrangement ha s been in
plac e since 1970 . In lieu of
funding and maintaining a
medical sc hool , the s ta te

D ecember
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develop ed "a coo rdinated
program of pr em edical,
medi cal , and grad ua te
ed ucatio n am on g s tate public
institution s of high er learning,
Delaware ho spitals, and
Jefferson Medi cal Co llege. "
Th er e is furth er give-a nd- take
in that many Jeff s tude nts
receive clinical traini ng from
Delawar e ph ysician s at the
Medi cal Ce nte r of Delaware,
th e Wilmington Veterans
Med ical Cente r, o r the duP ont
Hospital for Children, a close
affiliate of Jefferson . JI

B

a OKS

ALS Diagnosis

Manage Diabetes

J erry M. Belslt '75 is one of
two Editors of Amyotrop hic
Lateral Sclerosis: Diag nosis a nd
Management for the Clinicia n,
published by Fu tura Publishing.
408 pages, 43 ill us tra tions, $90.
ALS is also known as Lou
Gehrig's disease or motor
neuron disease. Dr. Belsh is an
Associate Professor of Clinical
eurology and Director of
the Neurom usc u lar and ALS
Ce nte r at UMDNj-Robe rt
Wood j ohnson Medi cal School.

Martin M. Mandel '4 7 of Blue
Bell , PA ha s just publish ed
Diabetes: Don't Fear It , Beat It!

Changes in Care
Barry C. DOni '6 7 is coau thor of Renegotia ting Health
Care, published by jossey-Bass
of San Francisco. The book
grew ou t of Dr. Dorn's teach ing
as Associate Director of th e
Program on Health Ca re
Nego tia tion at th e Harvard
School of Public Health. He is
also a Clinical Professor of
Orthopaedic Surgery at Tufts
University School of Medic ine.

Varied Advice
Thomas D. Meade '83 of
Allentown, PA is th e au th or of
The Medical Advisor, publish ed
by lCS Books, Merrillville , IN.
It is a co llec tio n of advice
about medicine co llec ted by
Dr. Meade since beginning
medical school in 1979.
Co ntr ib utors incl ude jefferso n
alumni an d facu lty members.

My StOlY , My Mcssagc, My
Mission. Dr . Mandel h as a
neu rol ogy practi ce based at
Holy Red eem er Medi cal
Ce nter in Mea dowbrook , PA.

High Excitement
E. Mars'Jall Goldberg, M.D. ,
Professor of Medi cine at
jeffers on , ha s three works of
fict ion ava ilab le at th e
Tho mas j efferson Un ive rsity
Book st or e (for con tac t
in forma tio n , see page 38 of
th is magazine ). They are th e
med ical th rill ers A Deadly
Operation ($ 14 .95 paperback ) ,
Intelligcncc ($ 14 .95
paperback ) , and The Family
Scalpel ($ 25.00 cloth , $13.95
paperback ) . Published by
Dufour Editio ns.

Alaskan Frontier
C. Ea rl A lbred lt '32 is the
subject of Frolltier Phy sician
by Na ncy j ordan , publish ed
by Epicen ter Press (Box
8 23 68, Kenmore, W A 98 02 8) .
Alas ka's first fu ll-time
Co m miss ione r of Health,
Albrec h t was credi ted with
revolution izing health ca re in
th at sta te. In 1963 h e became
a member of j efferson 's
faculty as a Professor of
Preventive Medicine.

New Clinical Text An Admi red Life
A lvin F. Goldfarb, M.D .,
Pro fesso r of Obs te trics and
Gynecology at jefferson , has
edited Clinical Problems in
Pediatric a nd Adolescent
Gy nccology. Various co ntributors, 118 pages , illu st rat ed .
Publish ed by Cha pma n and
Hall , New York .
26
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Carl S. Lytle '32 of Ocala, FL
is th e subjec t of The Etema!
Optimist, writte n by Peg
Masi no , R. . and publish ed
by Lifestyles Press . Its account
of Dr. Lytl e's experiences as a
ge ne ral pr actit ion er in cludes a
cha p ter on his medi cal sc hool
years at jefferson.
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The Raymond C. Gra ndon '45 Lecture was delivered by Mark
D. Smith. M.D.. M.B.A. (at right above. with David B. Nash. M.D..
M.B.A.. Director of Health Policy and Clinical Out comes). Dr. Smith
is Executive Vice Pres ident of the Kai ser Family Found ation. and
past Executive Director of the Philadelphia Commission on AIDS.
The next Grandon Lecture will be May 15 at 8:00 A.M. in DePalma
Audito rium: the speaker will be Karen lgnagnt. President and CEO
of the American Association of Health Plans.

New Inflammatory Bowel Disea se
Center is Announced
h omas j efferson
University Hospital ha s
estab lish ed an In flam mato ry
Bowel Disea se Center. Th e
center's main fun cti on is th e
diagn osis and tr eatment of
pati ents with infl ammato ry
bowel disease (Cro hn's
dis ease, ulcerative co litis ,
co llagenous colitis , and
microscopi c co litis .) Patien ts
with uncomplicat ed disease
will continue to be treat ed by
their ph ysicians. Referrals are
acc epted for such pati ents
from th eir ph ysicians.

T

The ce nter is staffed by expe rt
mem bers of th e Division of
Gastro enterology and
Hepat ology an d by gene ral
and co lo rec tal surgeons with
specia l int er est and skills in
dealing with infl ammatory
bowel diseases. Exp ert s from
radiology, pathology, and
o the r spec ialties pro vid e
addition al co ns u ltatio n.
O ut standing facilities offer
up -to-date and evolving
modalities for on e- tim e
D e c emb e r 19 9 6

evalua tio n, second opinions,
or lo ng-term treat men t.
"In flammato ry bowel disease
ra nges fro m mild to severe to
life-threat eni ng," says Franz
Go lds tei n '53, Professor of
Medi cin e and ac ting director
of th e ce nter. "T here are one
to tw o milli on people in the
United Sta tes wh o suffer from
bowel disease. Th is is a
disease which requires m uc h
atte nt ion ."
Dr. Go lds tei n has been
affiliated wi th Jefferson for the
last 40 yea rs. He was awarded
a mast ersh ip fro m the
Ame rica n Co llege of
Gas troe nte ro logy and has
autho red more th an 130
ma nuscripts , man y o n inflammatory bowel disease. Dr.
Go lds tei n was nominated by
co lleag ues as one of the "best
doct or s in the ortheast" for
inflammatory bowel disease.
The ce n ter is loca ted on the
fourth floo r of Main
Building.

S T A F F EARN
)oftn L. Abruzzo, M. D. ,
Professor of Medicine, has
been elec ted th e first Presid ent
of the Easte rn Pen nsylvan ia
Osteoporosis Soc iety.

Sa lman Aklttar, M. D.,
Pro fessor of Psychi at ry , ha s
received three honor s: Best
Pap er of th e Year Award from
th e Journal of the America n
Psy choanalyti c Associa tion for
his pap er , "A Third
Indi viduation: Immigration ,
Id entity, and th e
Psychoan alyt ic Pro cess "; th e
Mahler Literature Priz e from
th e Mahl er Psychiatric
Resear ch Foundati on for th e
same pap er ; and th e
Hasenbush Mem orial Visiting
Professorship at Harvard
Medical Schoo \.

Paul C. Brucker, M. D.,
Presid ent of Th omas j efferson
University , has been elec te d
by Grea ter Philad elphia Firs t
to its Board of Directors. GPF
is an association of bu siness
chief execu tives formed in
1983 with th e m ission of
ad van cin g eco no m ic growth
and th e quality of life in the
Delaware Valley.

Car lo M. Croce, M.D.,
Ch airman of Microbiology
and Immunology and Director
of th e Kimmel Ca ncer Center ,
ha s been elec ted to th e
Na tio na l Acade my of Sciences
in recogni tio n of his ac hievemen ts in resear ch .

Larry A. DorIOSO, M.D.,
PII.D., th e Du an e Pro fessor o f
Oph tha lmo logy a t j efferson
and W ills Eye Hosp ital , ha s
been honored by th e crea tion
of th e Lar ry Donoso Eye
Research Lab orato ry at
Qu een s Medi cal Center ,
No tt ing ham Uni versity, in
England .
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Robert D. Fry, M.D.,
Th e Marks Professor and
Dir ect or of Co lo rec tal
Surgery, ha s been
appo inted to th e Executive
Co u nc il of th e Am eri can
Soc iety of Co lon and Rectal
Su rgeo ns.

Mark Scllwei tzer, M.D. ,
Associate Profess or of
Radi ol ogy, ha s wo n th e
Scho lar Awa rd of th e
Radi ol ogical Society of orth
Ame rica , an award presented
to o nly four radi ol ogist s
per year.

Troy L. Thompson II, M.D. ,
T he Lieberman Professor and
Chairman of Psychiat ry , ha s
been elected to a three-year
te rm o n the national Board
of Direc tors of Alpha Omega
Alpha Ho no r Medi cal
Society.

A lvin F. Goldf arb, M.D. ,
Professor of Ob st etrics and
Gynecol ogy, presented the
Sir john Dewhurst Lecture,
entitled "Adolescen t Sexual
Behavior: Its Im pact on
Future Reproduction," at
th e 20th annual meeting
of th e North American
Society for Pediatric and
Ado lesce n t Gynecology.

Gerald). Herbison, M. D.,
Professor and Dir ector of
Resear ch in Rehabilitation
Medi cine, was honored by
th e Ame rican Acade my of
Ph ysical Medi cin e and
Rehabilitat ion as one of
its 1996 Dist in guish ed
Clin icia n Award recipients.
TllOfJlas B. Knudsen, PII.D.,
Asso ciate Professor of
Pathology, Anatomy, and
Ce ll Biology, has been
invited to serve as a charter
member of th e Human
Em bryo logy and
Development (2) Study
Section of th e National
Institutes of Health.

Dennis B. Leeper, PIt.D.,
Professor of Radiation
Oncology an d Dir ector of
Radi obi ol ogy, is PresidentElec t and Cha irma n of
th e Pro gr am Co m m ittee
of th e No rt h American
Hyp erthermia Society. This
society su ppo rts research in
th e mechanisms and us e of
hyp erthermia in th e
tr eatment of cancer.

C oll e ge

Alumn i

Bulletin

Receiving the award from lordan ,. Cohen. M.D .. AAMC President
(right) are (at center) Mary B. Mont eith . Executi ve D irector of the
Alumni A ssociation . and (left) Malcolm Clendenin. Associate Editor
and Designer of the Bulletin.

125th Anniversary Celebrati on Wins
National Award from Asso ciat ion of
American Medical Colleges
he 125th An n ive rsary
Celebration for th e
jefferson Medi cal Co llege
Alumni Associatio n has wo n
a nati onal prize from th e
Associa tio n of Ame rica n
Medical Co lleges. T he AAMCs
Awa rd for Excelle nce in
Public Affairs was presented to
j effer son for thi s multifacet ed
ce lebratio n of th e hist o ry and
future of th e medi cal co llege.
It included four issues o f th e
Bulletin cu lm inating in th e
special Spring 1995 issu e,

T
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a video , a Mayor's proclamat ion , an d enhanced eve nts
durin g 1995 with a spec ial
sc ientific symposium and ga la
Reunion Weekend . The
project's success wa s a co llaboration of the lead ership of
th e Alu mni Association and
th e professio nal talents of the
j effer son Medical College
Alu m ni Office . Among th e
j udges' co m ments: "Much to
cele bra te and you d id it so
we ll." "T he ma gazine cou ld
not hav e been better. "

EVENTS

RECOGNIZE

LJUISHE)

DIS

At the Dinner for

Class Agents and
Reunion ChainnCJ1
on September 30 are
(above) lohn T.
Comb er '9 1. Una P,
Sinha '91. and
Benjamin Bacharach
'56, Chair man of the
Presid ent 's Club .
(At left) L. Roy
Newman '4 9 and
Leon L. Berns '3D

The recepti on in the Rotunda

Euge ne F, Bonacci '56
and Sharon B, Mass '93
at the Class Age nts
Dinne r Sep tember 30
lo hn R, Prehatny '57
with Herb ert G.
Hopwood lr. '58
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Sidney Kimmel Receives Cornerstone
Award at President's Club Dinn er
id ney Kimmel wa s
hono red wit h the
Cornerstone Award at the
Preside n t's Club Dinner on
October 4 ,

S

a lo ng tim e s u p po rter o f
m edi ca l inter est s ,

In appreciation of a gift of
$ 10 million from the Sidney
Kimmel Fo undation ,
Jeffer so n's cancer cen ter was
nam ed the Kimmel Cancer
Ce nter ea rlier thi s year (see
the J u ne Bulletin) , Mr. Kimmel
is fou nd er and chairman o f
the J ones Apparel Gro up and

T he President's Club Din ner
wa s held at th e Ritz-Carlt on
and adjoi n ing Rot unda at
Liberty Place , th e smart
Ce nte r City co m plex of glass ,
blue metal , and gra nite
d esign ed by Helrnut j ah n.
Receiving special recogn ition
at th e d inner were 16 new
members o f th e Winged Ox
Soc ie ty and four new Fellows
of th e Presiden t's Clu b,

Dec ember

19 96

Herbert E.
Cohn '55:
Francis E.
Rosato. M .D .
(the Gro ss
Professor
and
Chairm an
or Surgery):
and Mel vin
L. Mo ses '62

Emanuel Rubin. M.D ..
the Apo nte Pro fessor
and Chairman or
Patho logy. A natomy .
and Cell Biol ogy.
and Robert L. Brent.
M .D .. Ph.D ..
the D istin guished
Professor and past
Chairm an or Pediatrics

Sidney Kimmel with
David L. Paskln '64
and Richard H.
Rot hman ORS '68

Dean and Senior Vice
President lor Ac ademic
Affairs loseph S.
Gonn ell a. M .D . and
K<lY Huebner. Ph.D ..
Professor or
M icrobi ol ogy and
Immunology

Uni versity President Paul C. Brucker. M.D .: Sidney Kimmel
(hold ing the min iature statue or Thoma s lefferson which was
presented to him) : Rena Rowan: Carlo M . Croce. M .D ..
Director or the Kimmel Cancer Center or Thomas leflerson
Uni versity: and Ioseph S. Go nnel la. M.D .. Dean and
Senior Vice Presid ent for A cademic Affairs
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OBITUARIES
Corrcction: Th e obituary in the
j un e 1996 Bullc/in o f Benjamin
Provisor '32 did not sta te th at he
is survived by his wife, Len or e,
of Passaic, J, and two
daugh ters. Dr. Prov iso r had
prac ticed in Passaic, after havin g
take n his postgradu ate train in g
in surgery at the Unive rsity o f
Pen nsylvan ia. Dr. Pro visor 's
gra ndso n, Eric P. Kleinbaum , is
cur rently a firs t-yea r stude nt at
jefferso n Med ical Co llege .
Louis F. Burkley Jr. '20 di ed
june 16, 1996 at age 99 years. He
practi ced obs te trics in Easton,
PA and se rved on the obs tetrical
staff o f Easto n Hospital, Easton ,
PA. He co- founde d the hospital's
pr en atal clini c and tau ght
obstetrics at th e hospital's
nursing schoo l for 35 yea rs. He
earne d th e nic kna me "Papa"
Burk ley beca use of h is co mpas sio na te devo tio n to pati ents . He
is survived by a da ug h ter.
Verne S. Cavi ness '2 1 die d
August 22, 1996 at age 10 1
years . He ope ned th e first
in tern al medici ne practi ce with a
specia l inte res t in card iovasc u lar
d iseases in Raleigh , NC in 192 3.
He served as Chie f o f Ge ne ral
Medicine at SI. Agnes Hospit al
and Chief of Card iovasc ular
Medi cin e at Rex Hosp ital ,
Raleigh , NC, and was a Fellow of
the Ame rican Co llege of
Physician s. He did pion eering
resea rch with insulin and on
hypert en sion and was listed in
America n Men oj Scicncc. He was
an Associa te Professor of Clini cal
Medicine at the Un iversi ty of
ort h Carolina Schoo l of
Medici ne, Cha pel Hill, NC. In
1985 he estab lished the Dr.
Verne S. Cavi ness Professors h ip
o f Investigat ive Med icine at th at
medical sc hoo l. In 1991 th e
school's Cli nica l Research Uni t
was renamed and d ed icat ed th e
Verne S. Cavi ness Ge neral
Clinical Resear ch Center. He is
survive d by a so n and two
da ug hte rs.
Bm cc A. Grove '26 d ied
February 10, 1996 at age 95
30
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years. He practi ced in York, PA.
He served as Head of th e
Dep artment of Op htha lmo logy at
York Hosp ital , York, PA for 25
yea rs . He was a Fellow of th e
Ame rican Co llege o f Surgeons
and th e Ame rican Acade my of
Oph tha lmo logy and a past
Presid ent of the York Co u n ty
Medi cal Socie ty. He is survived
by two so ns .
Reginald A. Allen '32 di ed
Aug us t 3, 1996 . He pra ctic ed
pediatrics in Pro vid en ce, RI for
53 years, retiring in 1988. He
was a member of th e New
England Pediatric Society and a
Fellow of the American Acad em y
o f Pediatrics. He is su rvived by
his wife, An ne tte, two so ns and
two dau ghters .

Georg e A. Baver '32 di ed April 8,
1996. He lived in Pennsburg, PA
and had pra cti ced famil y
medi cin e. He is su rvived by his
wife.
John Bower '3 3 di ed October 14,
1996. A member of Alph a
Omega Alp ha Hon or ary
Frat ern ity, he practiced
psychi at ry in Reading, PA. He
was Director of th e Dep artment
o f Psychi at ry and Neuro logy at
Reading Hospital and a Staff
Psychiatrist at SI. joseph's
Hospi tal, Reading. PA. He is
survived by three sons. Son j ohn
is jefferson '66 and son Edward
is j efferson '70.
Gilb ert M. Halpern '3 4 di ed july
15, 1996. He pra ctic ed gene ral
and occ upa tiona l medi cin e in
Hon olulu, HI and was on staff at
Quee ns Hospital in Hon olulu .
He was Med ical Director of th e
Dole Co mpa ny, Hon olulu, HI for
35 yea rs. He is survived by
seve ral chil dre n.
Benjamin P. Houscr '34 di ed
May 18 , 1996. He pract iced as an
eye, ear, nose and throat
specia list in Tamaqua, PA. He
was on staff at the former
Co alda le State Gen eral Hospital ,
Coaldale, PA, Gnaden Hu ett en
Memorial Hospital, Lehighton ,
C oll. e g e A l u m n i

Bull et in

PA and Pottsville Hosp ital,
Pot tsville, PA. He is survived by
his wife, Ruth , a son and two
dau ghters .

Dennot Lohr '34 d ied june 28 ,
1996. He practi ced public health
in Lexington , C. He was
associa ted with th e Smi th- Lohr
Clinic and Lexington Memo rial
Hosp ital , Lexin gton , NC. He is
surv ived by his wife, Blanc he ,
and two so ns.
Jo scp/J F. Hugh cs '35 di ed
Septembe r I, 1996 . A boardcertified Gen era l Surgeo n and
Fellow of th e Ame rican Co llege
of Surgeo ns , he was Ch ief o f
Surgery at Wilmington Medi cal
Cen ter and SI. Fran cis Hospital,
Wilmington, DE. After retiring
in 1979, he moved to Hon olulu ,
HI and worked as Med ical
Officer, disability evaluat ion,
Vetera ns Ad minis tra tion
Region al Office, Hon olulu, HI.
He is survived by his wife , Mary ,
two so ns , and a da ug h ter.
Franll M. Grem '4 0 died july 21 ,
1996. A board -cert ified
Anesthesiologist, he prac ticed at
Oak Park Hospital , Oa k Park, IL.
He held appoin tme nts as
Assista nt Professor of
Anes thes iology, Un iversity of
Illin ois School o f Medicine and
Professor of Anesthes iology ,
Loyola Un iversity Schoo l of
Dentistry. He se rved as
President, Ch icago Socie ty o f
Anes thes iologists in 1950 and
Presid ent , Illin ois Socie ty o f
Anes thes iologists in 1959. He is
surv ived by three dau ghters and
a so n. Son Philip is j efferson '76
and dau ghter jean is jefferson
'80.
Dale T. Ans tine '42 di ed October
15,1 996. He was an internist
wi th a subspecia lty of cardiology
and practi ced in Hollywood , FL.
He was a past Chief of Staff at
Doctors' Hosp ital of Hollywood ,
and a Fellow of th e American
Co llege of Cardio logy. He is
surv ived by his wife, Mab el, two
so ns , and two dau ghters.
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Riellard D. BausclJ '42 d ied july
19, 1996. He pra cti ced in
Allentown , PA and was a Fellow
of the Ameri can Acad emy of
Famil y Physicians . He was on
staff at Sacred Heart Hosp ital ,
Allentown , PA. He is survive d by
his wife , Emma, four so ns, two
da ughters, a stepson , and a
stepdaughter.

JO/III W. Galson '42 died Augus t
9, 1996. He practiced int ernal
medi cin e in Philadelphia, PA and
was on sta ff at Presbyterian
Hospit al, Philadelphia , PA. He is
su rvived by his wife, Margaret, a
so n, and two daught ers.
Stephen ] . Mm1/JOusc '42 died
Sep tember 6, 1996. He
maintained a gen era l practic e in
Lewistown , PA for 35 years. He
is survived by his wife, Harri ett e,
th ree sons, and two daughters.
Sta nley N . C1arll S'44 di ed
May 9, 1996 in Provo , UT, it has
bee n ascertained .
Davi d A. Culp S'44 di ed Oc tobe r
7, 1996 . A board-certified
urol ogist, he was Professor and
Chairman of the Department of
Uro logy , University of Iowa
Co llege of Medicine , Iowa City.
He co ntri buted man y articles to
th e ur ologic litera ture and coau tho red th ree books. A Fellow
of the Ame rica n Urologic
Associa tio n, he lat er served as
Presid en t of the organization. He
is survived by his wife, Anna ,
three so ns and two daughters.
StCf'/ICJI Soro/lanielJ S'44 died
Apri l 27 , 1996. He was a Ge neral
Prac titioner in Old Forge, PA. He
is survived by his wife and so n,
Stephcn jr., who is j efferson '8 1.

Dra m R. KlineJr. '45 died
September II , 1996 . A board certified Ophthalmologist . he
held staff appointments at
Coo per Hospi tal, Camden , Nj ,
Un derwood Hospital ,
Woodbury, Nj , and Wills Eye
Hospit al , Philad elphia, PA. He
held a j efferson faculty

appointment as Clinical
Professor of Ophthalmology and
served as President, ew Jersey
Ophthalmologic Society in 1970.
He is survived by his wife , Sue
Ann , a son, and a daughter.

Rocco P. Sci ubba j r. '45 died
Augu st 1, 1996 . He was in
general practice in Broomall, PA
and held a staff appointment at
Haverford-Mercy Hospital,
Ardmore, PA. He is survived by
his wife , Jeanne, two sons and
two daughters.
1. Ralpl. BlIJvridge]r. '4 6 died
August 19, 1996 . Certified by the
American Board of Psychiatry
and eurology, he practiced in
Eric, PA. He held a staff
appointment at Hamot Medical
Center , Erie , PA and a teaching
appointment at Western
Psychiatric Institute , Pittsburgh ,
PA. He is survived by his wife,
Olga , four daughters, and son
Geoffrey, Jefferson '77 .
Edwi n M. Mszanowslli '4 7 died
August 14, 1996 . A General
Surgeon , he pra cticed in Erie ,
PA. He was a full time member
of the active surgical staff at
Hamot Medical Center, Erie , PA.
He is survived by his wife , Millie ,
two sons, and three daughters .
C1larles R. Bal1on]r. '48 died
November 3, 1996 . He was in
general practice in Glenolden,
PA and served as borough Health
Officer. He relocated to
Scottsville, VA in 1970 and
practiced as a Country Doctor
until retirement in 1981. He is
survived by his wife , Marjorie ,
and four sons.
C1larles G. St einmet z HI '48
died September 16, 1996. A
board-certified ophthalmologist ,
he was on staff at Bryn Mawr
Hospital , Bryn Mawr, PA and
Wills Eye Hospital , Philadelphia,
PA where he had served as Chief
of the General Ophthalmologic
Servic e. He was a Clinical
Associate Profe ssor of
Ophthalmology, Jefferson

3I

JEFFERSON

Medical

Medical College. He is survived
by his wife, Megan, a son , a
daughter, and two stepdaughters.

Roben L. Eva ns '52 died October
22, 1996. A board-certified
internist, he had a distinguished
career in medical education,
including teaching appointments
at jefferson Medical College and
the University of Maryland. He
was the first Director of Medical
Education at York Hospital , York ,
PA and , in 1995, the Education
Building at York Hospital was
named in his honor. He later
served as the founding Dean of
the University of lIlinois School
of Medicine, Rockford, IL, and as
President of the Cooper Medical
Center, Camden , J. A member
of numerous medical and
educational organizations, he was
President of the Association for
Hospital Medical Education . He
served as an Alumni Trustee on
the Board of Trustees of Thomas
Jefferson University, 1971-1977.
He is survived by his wife , Peggy,
and two sons.
Louis]. W agne r '52 died
September 28, 1996 . A boardcertified general and thoracic
surgeon, he practiced in Oil City ,
PA. He was on staff at the
Franklin Regional Medical Center,
Franklin , PA. He is survived by
his wife , Mary , and a daughter.

Robel1 N . Cottone '5 6 died July
21 , 1996. A board-certified
Urologist , he practiced in
Trenton , J. He was on staff at St.
Francis Medical Center, Trenton,
J where he was Chief of Urology
and a former President of the
Medical Staff. He is survived by
his wife, Jackie, five sons, and
two daughters.
Howard S. Silven na n '83 died
August 21 , 1996. A noted
researcher and clinician, he was
an IH-funded cellular ph ysiologist and an Assistant Professor
of Medicine, Johns Hopkins
University School of Medicine ,
Baltimore, MD. He is survived
by his wife , Roseanne, and
two sons.
C ollege Alumni

Bulletin

Harold L. Israel '34
noted pulmonary disease
researcher and clinician and
an Emeritus Professor of
Medicine at Jefferson , Harold L.
Israel '34 died November 22,
1996 . His major clinical interest
was sarcoidosis and his work on
this disease received int ernational recognition. He had been a
member of th e International
Committee on Sarcoidosis since
1958 and was Vice President
of the 10th International
Co nference on Sarcoidosis

A

Gustave Edward Zerne OTO '53
died July 12, 1996 . He received
his postgraduate education in
otolaryngology at jefferson and
practiced in Lebanon, PA.
] . Leonard Ivins P'66 di ed
October 20, 1996. He completed
a psychiatry residency at
Jefferson . He was on staff at
Haverford State and HaverfordMerc y Hospitals, Haverford , PA,
and Belmont Hospital and th e
Institute of Pennsylvania
Hospital , Philadelphia, PA. He is
survived by a son and two
daughters.
Margaret Ril ey Scim eca P'78
completed a psychiatric
residency at Jefferson . She died
on an unknown date in 1996 , it
has been ascertained . She is
survived by her ph ysician
husband .
]ole C. McCu rdy P'81 completed
a psychiatric residency at
Jefferson. He died on an
unknown date in 1991, it has
been ascertained .
Su zarUle M. W est er OBG'88
completed a residency in
obstetrics-gynecology at
Jefferson . She died January 9 ,
1996 , it has been ascertained.

December 1996

in 1984 . A f~miliar figure on the
Jefferson cam pus , Dr. Israel
held man )' imp ort ant posi tion s
during his caree r incl udin g
Assistant Director, Tub ercul osis
Division , Philadelphia
Department of Health ; Assista n t
Visiting Physician and Visiti ng
Physician , Phil ad elphia Gene ral
Hospital ; Pulmon ary
Co ns u lta nt, Valley Forge Arm y
Hospital , Philadel phia aval
Hospital , and Wilmingto n
Veteran s Ad m inistra tio n
Hospital ; Member , Natio nal
Heart and Lun g Institute Tas k
Force on Resear ch Approac hes
to Respiratory Diseases; and ,
since 1976, an Hon or ary
Member, British Thoracic
Soc iety,
Following a two-yea r internship
at Philadelphia Ge ne ral
Hospital , he pursu ed his
int erest in pulmon ary diseases
at th e Henry Phipps Institute,
University of Pennsylvani a and
earned an M.P.H. degree from
the University of Pennsylvani a
in 1942 . He s pe nt three years in
th e U.S Arm y Med ical Co rps
during World War II, attaining
th e rank of major. Following
teaching appoi nt me nts at the
University of Pennsylvan ia,
W om an 's Medi cal Co llege and
th e Graduate Schoo l of
Medi cine, Univ ersit y of
Pennsylvania, he returned to
Jefferson in 1959 as Clinical
Professor of Medi cin e. He was
mad e Professor of Medi cine in
1972 . On his ret irem ent in
1982 , he was mad e Emeri tus
Professor and was awa rded the
Dean 's Medal in recogn ition of
his many co n tr ibu tions to
medical ed ucation , clin ical care,
and innovative resear ch . Over
his career Dr. Isra el publish ed
201 scient ific articles. He is
su rvived b)' two so ns , two
daughters, and two stepsons.
Son Dani el is J efferson '67.

Gartland Elected Alumni Trustee
oh n J. Ga rt land S'44 was
elec ted an Alu m n i Trust ee
th is yea r th rough th e ball o t
th at was mail ed to eac h
j efferson grad uate, includi ng
p ost graduat e alu m ni .
T he j am es Ed wa rds Professor
Eme ritus of O rt ho paed ic
Surgery at j efferson Med ical

Co llege, Dr. Ga rt la nd h ead ed
th e d epartm ent from 19 70 to
198 5 . He is th e au tho r o f

Fundamcnuiis of Orthopaedics,
a pa st President o f th e
Ame rica n Acade my of
O rt ho paed ic Surgeons, an d
a fonn er Ass oc iate Ed ito r o f
th e [ourn a! of Bone and.Joint

Surgery.

'32 65th Reunion lunc 6· 8
Nathan S. Sd llezinger o f
W yn cot e, PA was o n s tage at
th e Aca de my o r Mu s ic at
Co m me nce me n t las t june
when his gra ndso n, j effr ey A.
Sim o n, M.D ., grad ua ted in th e
Class o f '96. Dr. Sch lez inger is
an Eme ritus Professor o f
Ne uro logy .

'42 55th Reunion lune 6-8

J. Arthur Steitz o f Medford ,
Nj has retir ed a nd is
"e njoying b eing in a
retiremen t community."

Miller Receives
ASME's
Holley Medal

'47 50th Reunion lune 6-8

'46

Dr. Mill er was the research
associa te of j ohn H. Gibbo n
jr. '27 from 19 50 to 19 53 ,
an d th rough hi s co lla borati on , th e h eart -lu ng
mach in e d evel oped th e
n ecessary co nt ro ls an d Iluid
m echanics and feedback
co n trol sys te ms to ena b le th e
first s uccessfu l o pe n- hea rt
ope ra tio n in th e wo rld .
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Jam es T. Helsper or Pasadena ,

David G. Simons o f
Huntingt on Beach , CA is

B

ern ard J. Mill er '43
received th e prest igi ous
Holl ey Med al o n Novem be r
20 at th e an n ual int ernational meeting o f th e
Ame rica n Soc ie ty o f
Mech an ical Eng ineers
(ASME) in Atla n ta. Th is
awa rd was es ta blis he d in
192 4 to h onor Alexande r
Lym an Holl ey. It wa s give n
this yea r to Dr. Miller for th e
innovative ap p licatio n o f
fluid mech anics in the
d esign o f a feedback co n tro l
sys te m ena b ling th e h ea rt lung machine to ass ist wi th
an ope n -hea rt ope ra tio n
p erformed for th e firs t time
on a human bein g in Ma y
1953 .

co m ple ti ng h is second
ge nero us U.S. Scientist Award
from the Alexander von
Hum bol dt Foundation . As a
res u lt o f h is collaboration
wi th Pro fesso r Siegfried
Me nse at the University or
Heidelberg , Dr. Simons
s ubmi tted a paper with
Pro fessor Meuse that received
a co m pe ti tive award from th e
Stra th mann company , th e
Forderpreis Muskelrelaxation
(com pe ti tive award fo r the
best pap er o n the s ubject of
muscle relaxation) .

In addition to thi s impo rta nt
wo rk, Dr. Mi ller has carried
ou t research on th e furt her
design and d evel opment of
heart- lung machines ; and th e
use o f ex traco rpo re al circ u its
for th e treatment o f malign ant
tumors o f th e ex tre m ities with
hi gh -d ose cance ricida l age n ts ,
w hil e th e ci rc u latio n o f th e
ex tre m ity is iso lat ed during
tr eatmen t by an ex traco rp orea l circ u it and th e esc ape
o f drug to th e ge ne ra l
circ u la tion is minimi zed .
Dr. Mill er h as ta ught an ato m y
a t j efferson for mo re than 40
yea rs as a fu ll Professor and
curre n tly is an Honorary
Assoc iate Professor in th e
surgical d ep artment. He
received an h onorar y d egr ee
o f Doctor o f Scie nce from
Villa no va Un ive rs ity in 198 2.
T h ree o f hi s five ch ild re n , as
well as h is so n -in- law, are
jeffer son grad ua tes.
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CA has been a ppoi nted
Pro fessor o f C linical Surgery

Please submit news for Class Not es to:
Attention: Alulllni Bulletin
j efferso n Me dical College of Th o mas jefferson Un iversi ty
10 20 Locus t Street, Su ite M-4 I
Philadel p h ia, PA 19107-6799
Would you lille to contact the Alulllni Offi ce electronically?
If so, yo u can se n d yo ur name , cla ss yea r/specialty, and
in form ati on suc h as address ch anges or per sonal and
professiona l cha nges to : jmca/ums@jeflin.tju.edu. T he
e-mail add ress of th e Bull etin is : ied/72w@tjuvm.tju.edu.

Readers are encouraged to submit '1OIIIi"ations fo r:
1) Alulllni Trustee of Thomas jeffel"Son Univers ity: One is
elected eac h year for a th ree -year term ( he or s he may be
reel ect ed for one additio na l term ) . Please s u b m it names of
worth y ca nd idates to "Atte n tion: Alumni Trust ee Com mittee ,"
10 20 Loc us t Street , Su ite M-4 I , Philadelphia , PA 191 0 7.
2) AluJlJni Ad,ieveJlJent Award: Alth ough th e award carries
n o m o n etary s tipe n d, eac h recipient's name is perman entl y
affixed to a p laq ue promin ently displayed at th e en trance to
jefferson Alu m n i Hall. T h e recipi ent is pr esented with a
h an d som e silve r tra y, s u itably eng ra ved and bearing th e sea l
o f th e medical college, as the highlight o f th e Alu m ni Banq uet
each j une. The Ac h ieveme n t Awa rd Co m mi ttee of th e Alumni
Associatio n is ch arge d with th e fina l selectio n; th e committee's
d ecisi ons ar e n o t su bject to review . Please dir ect curricu la
vi tae and bibliographies o f alu m n i w hose p ro fessiona l
ac tivities are s u fficien tly outst andin g to wa rra n t co nsideration
to "Atte n tio n : Ac h ieve me n t Award Co m m ittee, "
102 0 Locust Stree t, Su ite M-4 I , Philadelphia, PA 19 107.
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(fu ll- time faculty) a t th e
Un ive rsi ty o f So u the rn
Ca liforn ia School o f Medi cine
in Los Ang eles .

atio na l Phil anthropy Day
lunch eon ,J. W allace Davis '42
and Be'yamin Bacha rach '56
have been honored by
jefferson Medical Co llege.

'48
Euge ne P. Htlg/,es o f
Plym outh Meeting , PA h as
re tire d an d is d oing much
go lfing , hunting , an d fishing .
His wi fe, j an e, has acce p ted a
positi on as President o f
Whitemarsh Valley Co u nt ry
Clu b.

'49
Th e Albe rt Eins tein Soc ie ty
honored L. Roy Newma n o f
Elk ins Park , PA at its annual
d inner on Sep te m be r 25,
1996. Dr. ew rna n was
recognized for his se rvice to
Albe rt Eins te in Medi cal
Ce n te r and the Eins te in
Soc iety that s u ppo rts medical
research and innovative
pati ent ca re .

'52

Robert A. Hin richs of Co ro na
Del Mar, CA ha s limited hi s
practi ce to tw o to three days a
week, "so n ow m y golf is
better. "

Swa rt h mo re , PA was h onored
in ove rn bc r by C roze rCheste r Medi cal Ce nt er. The
occasion wa s th e Natio nal
Philanthropy Day lun ch eon
orga n ize d by th e Gr eat er
Philadelphia C ha p te r o f th e
atio na l Soc ie ty o f Fu n d
Raisin g Execu tives. Dr. Cla rk
cha ire d Crozet-C hes te r's
Medi cal an d Dental Sta ff
Cap ital Cam pa ign, whi ch
raised ove r $2 . 1 milli on for an
Ed u cation Ce n te r and
Ambulatory Care Pavilion .
Th e ce n te r is nam ed in hi s
honor. Dr. C lark is C hairma n
of th e Department o f
Medi cine an d Dir ector o f
Med ical Ed uca tio n at C ro ze rCheste r, and a member o f th e
Board o f Dir ect ors o f th e
C roze t - Keys to ne Health
Sys te ms. In pa st yea rs at th e
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cw Britain , CT
is s till practi cing ge ne ra l
ophthalmology. He has three
children , ages nine to 12.
Recentl y, he received th e
hi gh est license in amateur
radi o .

'61

'55

A '1/nu' . Meya o f Kingst on ,
PA is in private practi ce o f
hemat ology/oncol ogy in
Kingston . His wife, Barbara, is
his offic e manager.

Jo sepl, A. Hean ey of

William B. Pratt of Gallup ,

C u m be rlan d, WI is a locum
ten ens psychiatrist s pec ializing in for ensi c psychiatry for
th e sta te m ental health
sys te m . His wife , Mary Brust
Hean ey, ha s publish ed a book ,
Belovcd Stra ngc r: ReJlections on
Menta! Illness, drawing on
their years in psychiatry.

NM ha s been at th e Gallu p
Indian Medical Center as an
orthopaedi c surgeo n since
1987. His plan is to reti re in
"a bo u t tw o years ."

J . Donald Sdlllltz is happi ly
retired in Sh el bu rne , VT al ong
w ith Robert W. Luhens j r.

'57 40th Reunion Iune 6-8

Jam es E. Clarl: o f
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'54

Rtldolf Bee of

George A. Salverian o f
Huntingd on Valley, PA ha s
recently retired , with 43 years
o f devoted d edi cation
following hi s excellent
training at jeffer son . His wife,
llah , and famil y j oined him in
ce leb rating his retirem ent.

'58
Edwi n R. Co ncors of Ryd al ,
PA is s till active in practi ce.

Jo/m K. Krei der of Manheim ,
PA is enjoying tak ing care of
pri soner s at Dauphin Cou n ty
and Berks Co u nty State
Hospitals , and is enjoying h is
five wo n de rfu l gra ndc h ild re n .

'60

Jo/m N. Rig/,tmyer o f
Hamburg, PA ha s retired from
his famil y practice and from
hi s work at Wernersvill e State
Hospital. Dr. Rightmyer will
be th e Distri ct Governor for
Distri ct 74 30 Rot ary
Int ernati onal from july 1997
through 1998.

'66
Franklyn R. Cool: of
Carmichael , PA is feeling
excelle n t d espite a past
pn eumonect omy for lung
cance r.

Mid,ael P. Dolan o f ew
Orlean s , LA ha s n ow retired
as th e Medi cal Dir ector o f
Health Se rvices o f Lockh eed
Martin Manned Spa ce
Syst ems. He and hi s famil y
plan to remain in Ne w
O rlea ns. No w th ey hav e th e
time to go sailing in th e
Ca ribbea n!

'67 30th Reunion lunc 6 8

W ill iam H. MallOod o f
Flourtown , PA wa s elect ed an
AMA Trust ee in june 1996.

Co l lege Alumn i
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B ul l et in

Car l L. Sta nitsl:i of G rosse
Pointe Farms , MI is now on
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Bowman is Fi rst
Chair of Family
Medici ne at Penn

M

arj orie A. W . Bowman

'76 ha s b een

appointed th e first
Chairm an o f th e newly
created Dep artment of
Family Pra cti ce and
Co m m u n ity ledi cin e at
th e University o f
Pennsylvania School of
Medicine . Dr . Bowman
is a pa st Pre sident o f th e
Society of Teach ers of
Family Medicine an d is
President- Elect o f th e
o rt h Carolina Academy o f
Family Ph ysi cian ( u n til
h er appointment at Penn
s he chaired th e Department
o f Family and Co m m u n ity
Medicine at Bowman G ray
School of Medi cine of
Wake Forest Un iversity) .
" I've been invol ved for a
lon g time in growi ng family
m edi cine at aca dem ic
institutions," she says.
"I'm pleased to have th e
hands- on opportun ity to d o
this at Penn ."
Dr. Bowman is Edi to r o f
the Archives oj Family
Medicine and se rves on th e
ed ito rial board of the
journal oj the America n
Medical Association. She has
been elect ed to th e Institu te
of Medi cine o f th e atio na l
Academy o f Sciences.
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the Editorial Board of the

[ournal of Pediatric
Orthopaedics . He was also j us t
named Chairman of the
Education Committee of the
Scoliosis Research Society ,
succeeding Peter D. Piz zutillo
'70 of W ynnewood, PA.
Mau /Jew W hite of Gig
Harbor , WA has expande d hi s
family medicine practi ce wi th
two new part ners.

'69
Richa rd Gross o f G ra n ite Bay,
CA passed th e CAQ
(Cert ifica te of Ad de d
Q ualificatio ns) Boa rds in
lnterveru ion al Rad iology
(Vascular Radiology) in
ovember 1995 .

'70
L a n )' S. Co heu of

orth
Miami , FL is now the Medical
Director of W illiams Island
Medical Group . Larry and his
wife , Rona , celebra ted th eir
25th wedding an niversary on
J une 20 .

Ne il O. Thompson o f
Balti mo re , MD re tu rns to
T ha ila nd in December 1996 .

'71
Chri stopher K. Ballwny of
St. Cloud , MN has become
board-certified in endocrinology and metabolism .
josep/J L. Se ltzer of

'72 25th Reunion June 6-8
St even A . Ager of Che rry Hill ,
J was voted by New J ersey
p hysicia ns to be one of the
psychiatrists by who m th ey
the mse lves wo u ld m ost wa n t
to be tr eated , in a poll
co nd uc ted by New Jersey
MO llthly and released in its
Ap ril 1996 To p Docs iss ue.

'73
Paul A . Bialas of Warren , PA
co n tin ues in active ge ne ral
internal m edici ne p ra cti ce in
W arren , PA. He se rves as Vice
Pres ide nt o f th e Medi cal Sta ff
and is a m ember o f th e Board
o f Tr us tees at Warre n Ge ne ra l
Hosp ital. Governo r Ridge has
j ust ap poi nted Dr. Bialas to a
five-year term on th e Warren
Sta te ( Psychiatric) Hospital to
commence in Jan uary 199 7.

Leland D. Cropp er Jr. of
Oilville, VA has a privat e
practice of vascu lar and
interventio na l rad iol ogy and
d iagn osti c rad iology. He is
now Chief of Radi ology at
Healthsouth Medical Ce nte r
in Richmond , VA.
joanna R. [ohnson o f
Malvern , PA married David
J ohnson Jr. o n Oc to be r 8,
199 5. Co ng ra tu la tio ns!

Richard M . Sostowski of
Livin gst on , NJ recently passed
th e s ubspecialty boards in
forensic psychia try.

Rosemont , PA has been
elected President of the
Societ y of Academic
An esthesia Chairs for a
two-year term .

W ill iam A . DiCuccio of

34
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'74
Butler, PA is the Medical
Directo r for Su n nyview
(Butler Co u n ty's nursing
hom e) and Butl er Co u nty
Prison .

A l u mni
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Mel issa R. Sp evak of

Dr. AshleyGilb er t

'76
A,m As/dey-Gilbert and
Genester Wilson King '82,
both of Alta mo n te Springs, FL,
alo ng with Billie J ean Pace ,
M.D., have formed "the first
women's grou p gynecology
practi ce in Sem inole and Lak e
Co u nties" in Flo rida. The
Alta mo nte W omen 's Ce nter
o pe ne d in Sep te m be r 1996.
D r. King

Baltimore, MD and he r
husband , Phil, ar e both
working at J ohns Hopkins
Ho spital, she in ped iatric
radiology and h e in pedi atric
card iology . They ar e enjoyi ng
their children Sarah , age four,
and James, age 21 m onths.

'77 20 th Reunion lune 6-8
Dale N. Goode of Yardl ey, PA
is p rac tici ng emergency
m ed icin e in Trenton , NJ and
also enjoying oc cupational
m ed icin e at Lockheed-M artin .
He we nt to Russia and
Kazakhs tan in May.

'78
Bruce E. Nayowith o f
Rhinebeck , Y is working in a
small emergen cy roo m in th e
Ca tskills, and helping hi s wife
school their four chi ld ren at
home .

Sta te me n t o f Ow ne rs hi p, Man agem ent . and Cir cu latio n ( PS Form 3526 )
(req uired by 39 U.s.c. 3685, Un ited States Postal Service )
I . Publ icati on tit le: )rffcrsoll Mrdi w/ Co//<:gr A/ulllni Bullrlin
2. Publi cati on number : 0021 5821
3. Date of filing: 10/9 6
4 . Issu e frequen cy: four per yea r
5. Nu mbe r of issues published an nua lly: four
7. Co m plete ma iling add ress of office o f publication :
Su ite M-4 I , 1020 Locu st Stree t, Philadelphia, PA 191 0 7
8. Mailing address of gene ral bu sin ess office o f publish er: sa me as above
9 . Publisher: Jefferson Medi cal Co llege o f Th om as j efferson Un iversity (add ress above)
Editor: Mary B. Monteith (add ress above )
Man agin g Ed ito r: Malc olm Clende nin (add ress above )
10. O wne r: Jeffer son Medi cal Co llege of Th om as Jeffer son Universi ty (add ress abov e)
II . Bondhold er s, m ort gagees, a nd othe r sec u ri ty hold ers ow ni ng or hold ing one percent
or mor e of to tal a mo u nt o f bonds, mort gages, or othe r securities : none
12. For nonprofit orga niza tio ns au tho rize d to mail at specia l ra tes:
th e pu rpose, fun ct ion , and nonpro fit sta tus o f th e o rgan izatio n, and the exe mpt status
for Fed er al in com e tax pu rposes have not cha nged d ur ing the pre ceding 12 months
15. Exte nt and nature of circu lation
Average umber Copies Act ual , umber Copies
o f Each Issue Duri ng
of ingle Issu e Publi sh ed
carcst to Filin g Dat e
Preced in g 12 Mont hs
18,500
18,500
A. To tal number of co pies (net press run )
B. Paid and/or req ues ted cir culatio n
I . Sales th rou gh dealer s, ca rr iers ,
0
street vendo rs, co unte r sa les
o
2. Paid and/o r requested mail subsc riptions 17,900
17.900
C. Tot al paid and/or requ est ed ci rcu lation
17,900
17,900
D. Free distribution by mail
290
290
E. Free d is tribution outside th e mail
300
300
G. Total distributio n
18 ,490
18,490
H. Copies not distributed
10
10
I. TOTAL
18 ,500
18 ,500
Percent paid and/or req uest ed cir culation
97%
97%

D e c em b er

19 9 6

Pract ice Residen cy. His fam ily
now include his wife, Susie ,
and th eir six chi ld re n, Kati e,
Beck y, Michael, Caroline ,
Elizabe th , and And re w.

Scott M. Goldman '76 of Philadelph ia (third from left. above)
was the special hono ree November 21 at the testimon ial dinner
of the Main Line Division of the American Heart Associatio n of
Southeastern Pennsylvania. He's o ne of the yo unges t individuals to
be honored in this way. With him in this photo are Lawrence Frame.
M.D.. President of the AHA of Southeastern Pennsylvania: Harmon
Spo lan. Pres ident of leflerson Bank: and Peter Kowey . M.D.. Chief
of Cardiovascular Diseases at The Lanken au Hospital (a member of
the Iefferson Health System).

Ne il H. SJlUstennan of
Wyn newood , PA is enjoying
pharmaceutical med icin e at
Smith Klin e Beec ham . Dr.
Shusterman is in cha rge of
worldwide development of
cardiovasc u lar and re nal
drugs.

'79
Thomas]. MarsJwll]r. of
Arlington , TX was recent ly
appointed Director of Surgery
and Surgical Subspecia lties for
Kaiser Permanente , Southwest
Divisi on , based in Dallas .
Brian R. Ott of Barr ington , RI
was promoted to Associate
Professo r in th e Dep artment
of Clin ical Neurosciences a t
Brow n Unive rsity School of
Medicine .

'80
St eph en A. Geraci of
Germantown, T is Associate
Program Director , Medici ne
and Cardiology at th e
University of Tennessee and
35
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Assista nt Ch ief of Medi cin e at
th e Vetera ns Ad minis tra tio n
Medical Ce nter in Memphis.

'82 15th Reunion lune 6-8
Christine C. Gamburg of
Berwyn , PA is in a clin ical
anes thes ia pr act ice at
Delawar e Co u nty Co m m u n ity
Hosp ital. She is also th e
Directo r of Drexel Anes thes ia
Pain Clinic .

Thomas D. Meade and
CJwrles Norelli , both of
Allentown , PA, se t a Masters'
World Record in swi mming
thi s year in th e 200-meter
freest yle relay. Dr. o relli
won six individual eve n ts and
o ne second place at th e U.S.
Mas ters Swi mming Na tio na l
Cham pio ns hips in Cu pe rt ino ,
CA. Also th is past yea r, Drs.
Mead e and orelli , who tr ain
together , br ok e ano the r wo rld
record , in a four-man team
eve n t.
Dr. Meade pr esented h is
resear ch o n "Fe mo ral Nerve
Block Allowing Pred ict ab le
O u tpa tient AC L Surgery" at
the North Ame rican
Art h rosco py Assoc iatio n
meetin g in Washing to n , DC.
He was also se lected as an
ort ho paedic co ns u ltant for th e
Philad elphia Eagles summer
cam p at Lehi gh Universi ty.

Gaty Y. Ott of Cincinnati , O H
ha s acce p ted a posit ion as
Associat e Professor of
Surge ry , Division of
Cardiot hora cic Surgery at th e

Unive rsity of Cinci nna ti
Medi cal Ce nt er. He also
ass umes du ties as Directo r of
Thoracic Transplantation . He
wo u ld love to hea r from an y
clas sma tes in the are a.

A nd rew B. Sattel o f
Moorestown , J recentl y
became a member of the
Ameri can Society for Surgery
of th e Hand and a Fellow of
the Ameri can Co llege of
Surgeons.

'84
Lo uis A. Knzal]r. of Ga nado ,
AZ is s till on the ava ho
Reservation in Arizo na. He
ha s been appointed Medical
Dire ctor of Sage Mem orial
Hospital and promot ed to
Clinical Associat e Professor of
Family Medicine at Baylor
Co llege of Medicine.

'85
Ha ny A. Coopen lJatl of
Voorhees , J is se rving as
Presiden t of th e Medi cal Staff
at Our Lady of Lourdes
Medical Center , Ca mde n , J.
He is a diagno sti c rad iologist
with Lourdes Radio logy
Assoc iates in Camden
Co u nty , NJ.

'83
Caml Boern er '76
of Boston with her
two six-month -olds
(llamas. that is):
Kismet and Mozart.
Dr. Boerner enjoy s
ge tting away to her
llama farm in
Vermo nt.

lauren E. Bid:el of
Owensboro , KY has deliver ed
a bab y boy. J ohn Timothy
Bick el was born o n July 20 .
Ti mmy j oins Emily, who
tu rn s three in J anuary. W hile
Dr. Bick el is enj oying h er fulltim e mother hood , she also
has a part-t im e family
pra ctice . May we say , "You go
girl !"

Timothy M. Heilmann of
W illia ms po rt, PA is an
Associate Dir ect or of th e
W illiamsp ort Hospital Family
C o llege A lumni

B ul l et i n
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Ralpll J. LaN eve of
Brentwood , T is now
pr acti cin g at Co lu m bia
Sum mit Medi cal Ce n te r in
Nas hv ille, TN . Ralph and his
wife, Caro l, have two
ch ildre n , David , age seven ,
and Bry n na , three. T he
LaNeve famil y mi ss o ur Philly
checsesteaks (tho ug h they can
now bu y Tastyk ak es).

'86
Robert L. Robles of Sa n
Fran cisco is an Assistant
Clinica l Professor in th e
Dep artment of Medi cin e a t
San Fra nc isco Ge ne ra l
Hospital. He practices
hem at olo gy, on colo gy, and
AIDS ca re .

'87 10th Reunion lunc 6-8
William E. BurallJr. of
Co lum bus, O H ha s been
ap po inted an Ass ista nt
Professo r of Surge ry in th e
Division of Surgical O ncology
at th e Ohio State Un ive rs ity
and Art h ur G . james Ca nce r
Hospital and Resear ch
Institute. He and his wi fe,
Sus an, just had an ad d itio n to
th e family. Alexandra Adela
was born july 15, 1996. Ryan
Step he n , th eir so n , turned
four in Oc to ber.
Caes ar A. DeLeo III o f
Evans to n, IL is now Asso ciat e
Med ical Direct or at C IGNA
Health Ca re o f Illin ois .
J ohn F. and Deanna Wilso n
are proud to announce th e
birth o f th eir daughter ,
Elizabe th Kirb y Shaw Wil son ,
bo rn j uly 22 . Eliza be th j oins
brothers j ohn , age II , Ritchi e,
I a , and siste rs Ca ro line,
se ve n, and Alexa nd ra, live.

primary ca re clinic a t Keller
Army Hospital. He's been a
family doct or now for th e pa st
eight years and plans on
"hang ing it u p in two years or
so ." Meg, his wife, works parttim e in an early interv enti on
progr am visiting ch ild re n with
possibl e developmental
delays. T he Hermans have
four ch ild re n: Kati e, wh o is
six; Sara, four; Erin , two ; a nd
Ada m , eig h t m onths. Th e
famil y hope to move back to
Philadelp hia soo n.

J ean M. Ne lson of Pfafftown ,
C has been promot ed to
Assistan t Professor of
An esthesia at Bowman Gr ay
School of Medi cin e in
Winst on -Salem , C. She had
been an Instruct or in
Anes thesia since 1992.

Jolm T. Rich Jr. of Clarks
Su m m it, PA ha s j oined an
ort ho pae d ic practi ce in
Scra nto n , PA afte r finishing a
hand surgery fellow ship at
Alleg he ny Ge ne ral Hospital in
Pittsburgh.
Craig G. Riclnnan of Eri e, PA
and his w ife, Linda , are th e
proud pa rents o f Stefa nie , age
th ree, and Eric , tw o. Craig is
Presid ent o f the Erie Co unty
Medi cal Soc iety and President
of a Ia -phys ician grou p,
Presque Isle Psychi atric
Assoc iates.

'88
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Kevin M. Zallrzewslli of
Horsham , PA ha s received an
appointment as Vice President
of Medi cal Affair s at Gr aduat e
Hospital in Philadelphia.

'89
N icl: Maravich ]r. o f Isle of
Palm s, SC proudl y an no unces
th e birth o f his seco nd
daughter , Brianna Brook e,
born j u ly 24. Nick also has
been ap po in ted Head of th e
Radi ol ogy Department at th e
aval Hospital in Cha rlesto n ,
Sc. He has co m pleted a novel ,
Fingers Uncrossed, whi ch is
awaiting publi cati on .

Pllilip S. Sclnvartz of Landstuh l, Ge rma ny has co m pleted
his fellow ship in rh eumato logy and sta rte d a two -year
tour as a rh eumatol ogist.
Andrew P. Sirotnak of Den ver,
CO has been ap po inted
Director of th e Ch ild
Ad vocacy and Protecti on
Team at th e Child re n's
Hosp ital in Den ver. He is also
Assista nt Pro fessor o f
Pedi atri cs at th e Un ive rsi ty of
Colo rado Schoo l of Medi cin e.
He is acti ve in th e Den ver
Cha pte r of th e America n
Aca de my of Pedi atrics , and is
a board member o f th e

Your diploma is from jefferson Medi cal Co llege
of Thomas jefferson University-please refer
to your degree in this wa y.

Grego ry E.' Hennan of West
Point , NY is in charge o f th e
36

Su zanne T . Sundll eim of
Boulder , CO is th e proud
mother of Co le Sco tt Voe lle r
Su nd he im , born Oc to be r I a.
Suzanne is also Co- Direc tor o f
Co ns ulta tive Mental Health
Services to Person s wi th
Devel opmental Disabilit ies , in
Progr am s for Publi c
Psychiatry, and Ass istan t
Professor of Psychi at ry at th e
Un ivers ity o f Co lo rado .
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Co lorado Professio na l Soc iety
o n th e Abu se of Chi ld re n
(CO PSAC) . He is a founding
member o f th e newl y form ed
Den ver Co un ty Chi ld Fata lity
Review Committee.

ClJarles D. Tullius of
Sava n nah, GA is now
pr acti cin g obs te tric an esthesia
at Cha nd ler Hospit al. He is
pleased to note that Kyrin
Duns ton '92 and Rcbccca
Hogue '90 are also in
Sava n na h. From time to tim e,
Dr. T ullius will do anesthesia
wo rk for RiclJa ,"d Grcco '83 at
his plast ic surgery ce nter.
Cha rles has two children ,
David , age two and one-half,
a nd Claire , age six months.
Prod romes Ve,-vereli of
Alle n town , PA is ce lebra ting
th e birth of his so n, Alexander
Rob ert , born Mar ch 2 1, 1996.
His dau ght er, Elizabeth , turned
th ree years o ld in june.
Madel inc S. Wood -Ciccllinelli
of W est Che ster , PA and her
hu sb and have o ne child,
Cari ssa Claire , who turns three
in Decem ber.

'90
Alicc R. Dicll of Los Angeles,
CA is now a s taff internist at
th e Medical Group of Beverl y
Hills , Inc., a division of th e
Ceda rs- in ai I-1 ealt hcare
Fo u ndatio n .
Marc ], Levinc of St.
Petersburg, Fl. ha s j oined
Ta m pa Bay Ort hopaedic
Spec ialis ts w ith office s in St.
Pet ersburg. T he group has
provi ded ad ult orthopaedi cs in
th at area for 25 yea rs. Dr. Levin
co m pleted his spine su rge ry
fellowship at Emo ry Univers ity
Hospit al last j uly . He is now a
dad as well as happily marri ed
to Robi ne, Benjamin athan
Levine celebrates his first
birthday in j an uary.

'91
Andrea E. Gordoll of Fede ra l
Way , WA completed a twoyear fellowshi p in Fam ily
Prac tice Fac u lty Developm ent
in Pittsburgh , PA th rough a
proj ect spo nso red by St.
Margaret Mem o rial Hospital.
W hile co m pleting her
fellowsh ip , she'd done a
resea rc h proj ect in a co m plementary medi cin e mod alit y
called Thera pe u tic To uc h,
whic h is curren tly bein g
prepa red for su bm issio n to a
jo urna l. And rea has s ta rte d
her new faculty positi on in
the rural br an ch o f th e
Tacom a Fam ily Pra cti ce
Residen cy Progr am in
Puyallup , WA .

'92 Fifth Reunion Ju ne 6-8
Kyrill D u nston ha s joine d
Cha tha m Ob-Gy n Associates
in Sava n na h, GA. She receiv ed
th e Resid ent Achieve me n t
Awar d fro m th e Soc iety of
Lap aro -Endoscopi c Surgeo ns
while a resid ent at th e Medi cal
Cen ter of Delawar e.
Stephen B. Kupferberg and
Marcia Liu o f Martinez, GA
are th e proud par ents of J acob
Eric Kup ferberg, now o neand-a- ha lf. They are at th e
Med ical Co llege of Geo rgi a
where Stephe n is co m pleting
th e last year of his o to lary ngology resid en cy, and Mar cia
is in th e second yea r of her
card iology fellowsh ip .
Maria E. Pharr of Havertown ,
PA has received a J efferson
facu lty appo intme n t as an
Assistan t Professor of Fam ily
Med ici ne .
Helell K. Sava of Honolulu ,
HI is th e proud m other of
Vince nt J am es Sava Ill , born
Februa ry 28, 1996 . Dr. Sava
is an atte nd ing ph ysician at
th e Tripier Army Medi cal
37
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Ce n te r Family Pra cti ce
Residen cy Pro gram .
Co ng ra tu latio ns to
C. A lItllOlIY Wolfe Jr. of
Baltimore, MD who proudly
announces his m arriage to
Lisa C. Bauman on September
7 in Gos he n, CT . Among
those in attendance at
th e ce re m o ny wa s Eva ll
Weismall '92. Dr. Wolfe is
curre n tly working as a
military ph ysician with th e
rank of Cap tain at Aberdeen
Provin g Ground , MD .

'93
Ga vill C. Barr of Springfield ,
NJ wa s named Chief
Resident in th e Emergen cy
Medi cine Program at New
York Unive rs ity Medi cal
Ce n te r. He will complet e
hi s training in june 199 7.
Ma ry Am I G. Hail es of
Hav ertown , PA and her
husband , Dave Trephan, ar e
th e proud parents of Brian
Alex ande r, born Ju ly 17,1996.
Michael C. So'wl of Fort Lee ,
NJ co m pleted his residen cy
in Preventive Medi cin e at
th e Un ive rsity of Maryland
Medi cal System in June.
Michael now ha s an M.5. in
additi on to an M.D . after hi s
nam e; he obtained a Master
of Science degree in
Epide m iology and Preventive
Medi cin e while doing his
residen cy. He is curre n tly
working for Mer ck-Medco
Managed Care in Montval e,
NJ as th e Asso ciate Dir ect or
of Ou tco mes and
Performan ce Assess me n t.

'96
David N. Ferraro J r. of
Pittsburgh , PA just had an
addition to th e famil y. Maria
Elizabeth was born April 8 ,
1996 to David and Melanie.
C oll e g e A l u m n i

Bull et in

A Green Thumb's Paradise
hile many of us ar e
facing snow, Edward
Scull '48 and his wife ,
Malelon, h ave escaped to
warm Nevis in the West
In d ies . On this isle of
eme ra ld foliage , mountains,
m onkeys, and wild do nkeys ,
Dr. Scull has cu ltivated
his inte rest in horticulture.
The Scu lls firs t visi ted from
Hartford , Co n nectic ut
(w here he also ga rdened)
in 196 2, and a year lat er

'T he MilL"
a Four-story
structure
dating from
about 1800,
houses
living and
slee ping
areas amid
the gard ens,

bo ug ht six ac res in cluding
some old ruins. In 198 2 Dr.
Scu ll retir ed from his 30-year
practice of rh eumatology, and
staye d on Nevis yea r-round.
He ha s raised mo re than 110
species of tropical frui t. Of
his 500 or chids , ma ny have
been "natur alize d" o nto
surrounding tr ees. "Every
plant wants to grow, " Dr.
Scu ll theorizes . "If it dies , it's
so m eth ing I'm do ing wro ng ."
-Malcolm Clendenin

Shop by Mail Orde
1 OlympicJM C T-Shin

SH.95

S, M , L. XL

2 Jackel : betge/blk, lined
S. M, L, XL, XXL
3 Baseball Cap: Wool/Suede
-l Turtleneck: white, beige

69.95
SI-l.95
S21.95

S, M , L, XL

8

5 Basic Crew: gra)', green, navy, burgu ndy
Available Hooded: gray, green. navy, burgundy
Available T-Shin: gray, green . na vv, burgundy
6 Alumni Sweatshirt
S, M, L, XL, XXL
7 J MC Heavyweight Sweat
8JMC T-Shin
9 Jefferson Boule Bag
10 Golf Shin Beige
S, M, L. XL. XXL
I I Knitted V-Neck Sweater
S. M, L. XL, XXL
12 Alumni T-Shin : navy, gray, burgundy
S, M, L, XL. XXL
13 Caduceus T-Shirt: while, gray
S, M, L, XL, XXL

7

l One Piece: Winged Ox
12M,18M. HM
2 One Piece: Cow Jumped Over
yellow or mint 6M, 12M, 18M, HM
3 One Piece: Short, Cow Jumped Over
6M. 12M. 18M, 2-lM
4 Jump Suit: Winged Ox
12M. 18M, 24M
5 Handp airued Bib "Rx 2 Hugs"
6 Hooded Sweatshirt JMC
6M, 12M, 18M, zr, H , 6, 8,10,12, H
7 JMC T-Shin : gray. white
6M, 12M, zr, H . 5
8 JMC Baseball Cap: one size
denim . orange , white
9 Scrub Set:
Bear Design 2T. -lT
Bubble Gum Pink zr , H , 5/6 , 7/8. 10112
Navy zr. H , 5/6 . 718, 10/12
Green zr, H , 5/6 , 7/8 , 10/12

9 .

•

7.!1r1l
1/t,rQ,0!ltq

2
~,/

• ~,..p.....

~

-,

57.95
S15.95
6.99
38.95
59.95
S15.95
SI 1.95

Kids ' Co rner

8

6

S29.95
S-l0.95
S H .95
S29.95

;~~

JEt :le •

'loc,"

-:'"

S17.95
16.95
S12.95
S16.95
S5.95
SH.95
S10.95
S8.95
H .95

~

Ship to: Na me

_

Fax yourorder to JEFFERSON BOOKSTORE fax 215923 1844

Add ress

or mail to BOOKSTORE. 224S, 11thStreet. Philadelphia. PA 191D7lphone 215955 7922)

Ci ty
tat e
a cash or C.O .D . please. Orders must be prepaid .
QTY.
PRICE

IT EM

DESCRI PTI O N

COLO R

SIZE

Shipping and Handling: If yo ur order tot als 510.00 o r less , add 53.00; SIO.OI to $25 .00 , add $4.00 ;

_

ME RCHA

DISE TOTAL

$25.01 or mor e. ad d $5.00. All item s se nt via U.P.S. Pleas e allow 2-3 wee ks for de livery.

Methodof Payment
Account
Signa ture

Check (payable 10 TJU Booksto re)

a Visa

Mast er Card

umber

o American Express

Discover

Expirat ion Dat e
Dat e of Orde r

I

I

PA res iden ts add 7% sales tax
except all clo thing
SHIPP I G AND HA DLI ' G

Daytim e Phon e

ReturnPolicy: If you arc 1I0t co mplete ly satisfied with th e mer chandise you have purch ased , simp ly return th e item
with a co py of the packin g slip and ind icate th e reason for the return. Your payment will be refunded within 30 days.

TOTAL

Zip

_
TO TAL

'om the Jefferson Bookstore
Crysta l Collec tio n
j MC engraved
(perso nalized engraving ava ilab le )
I Wa ll Clock: 15x26
2 Rever e Bowl
3 Rectan gul ar Clock
4 Pap erw eight
5 Wine Go blet
6 A ncora Vase

7 Snowfla ke Tree Ornament
8 Des k SCI (pen included )
Mar ble Bookends
Plan er ( no t s hown ) 20x l2
TlU: Tradition and Hcrilagc by Wagn er
1]U: C1lronological History by Wagn er
and Savaco ol
Gross Clinic Post er ( not sho wn )
Au to Mu g 140z
j effer son Ca nva s Lun ch Bag
Pap er Cube: Winged Ox , O lle r Fo unt ai n
Pewt er Glass Bouom Mug
Stein : 3 20z while/gold tri m
jM C Wat er Houl e
jM C Citize n Walch : Men 's
jM C Citize n Wal ch : Ladies'
Ti e: Pedi a tri c Doctor
Tie: Anatomical
a. DNA
h. Eyeball
c. Skele tal
d. Heart
Tie: jefferson colors, BVBlk si lk
jM C Scarf: Fa ux Silk
jM C Padf oli o
jM C Keych ain
jM C Licen se Plat e: Brass
Silver
j effer son Post card s
Noteca rds : Winged Ox
Pew ter Lett er O pene r
Duke Tankard : Pewt er

2

6

Cross Collect ion
I Fou nta in Pen & In k: Med alis t
2 Pen & Key Cha in ( Rollerball)
Med alist
Ch ro me
Class ic Black
3 Fo unta in Pen & Ink: Tit anium
4 Roll erb all Pen s
a. Black
b. Sien na
c. Gree n Marbl e
d. Medali st
e. Titanium
5 jM C C hro me Set
Availab le in Black
6 jM C Ballpoint Pen :
a. Black
b. Navy
c. Burgundy
d . Grey
Available in ch rome
7 Townsend Ballpoint Pen
a. Sienna
b . Black
c. Gree n Marbl e
d . Medalist
c. Titan ium
8 Townsend Penci l
a. Sienna
b. Black
c. Meda list
d . Gree n Marb le
e. Titanium

$ 199.00
$74 .95
$7 9.00
$49.95
$ 24. 00
$55 .95
$32.95
$77. 95
$89 .95
$79 .90
$ 120.00
$72. 00
$ 19 .95
$4 .99
$7.99
$5 .99
$3 0.00
$ 13.95
$3.99
$ 119 .95
$ 119 .95
$ 10.95
$29 .95

$22 .00
$36 .95
$7.99
$4 .99
$8 .99
$7.99
$.5 0
$4 .99
$2 1.95
$49 .95

$85 .95
$3 9.95
$3 1.95
$4 2.00
$85 .95
$79 .95

$3 3.95
$50.95
$ 26.95

$ 17.95
$52.9 5

$5 1.95

A.k Jo r OUI' cata log oJ mult imcdia soJ twQl'c and mcd ical " "I'l,lic s

